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Transforming growth factor beta (TGF-!) has been implicated in anterior
subcapsular cataract (ASC) development.  In the first section of this thesis, an in-vitro rat
lens model was used to determine the role of matrix metalloproteinases during TGF-!-
induced ASC.  In the second part, an in-vivo TGF-! transgenic and Smad3 knockout
model was used to examine the role of Smad3 signaling pathway in TGF-!-induced ASC
development. Lastly, an in-vitro rat lens epithelial explant culture model was used to
investigate the potential role of heat shock proteins (Hsps) in TGF-!-induced epithelial-
mesenchymal transition (EMT).  Optical, morphological and molecular changes were
analyzed in theses studies.
Results from cultured rat lenses show a significant increase of back vertex
distance variability (decrease of sharpness and focus) during ASC development.
Inhibition of MMPs eliminated the TGF-!-induced plaque formation. Similarly, the
overexpression of TGF-!1 in transgenic mouse lenses leads to ASC formation and a




lenses show diminished TGF-!-induced effects.  The plaques formed in the TGF-
!1/Smad3-/- lenses are substantially smaller than in the TGF-!1/Smad3+/+ lenses.  The
morphological and molecular changes of TGF-!2/FGF-2 treated rat lens epithelial
explants are similar to those found in the TGF-!2 treated rat lenses and transgenic TGF-
!1 mouse lenses.  Heat shock treatment prior to TGF-! treatment significantly reduced
the effects of EMT in rat LECs.
iv
In conclusion, MMP inhibition prevented TGF-!-induced ASC formation
whereas heat shock treatment and the absence of Smad3 protein expression only reduced
the severity of TGF-!-induced effects.
v
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General Introduction
The ocular lens is a transparent structure that provides part of the refractive power
needed to focus images on the retina of the human eye.  The lens grows throughout life
by the continuous addition of new fibre cell layers on top of older fibres, with minimal
protein turnover.
1
  Therefore, the cells in the lens nucleus were formed during the early
phase of embryonic development and the cells in the cortex are the newest.  It is
important that the lens maintains its native protein organization to function as an optical
device.
1, 2
  A cataract results in reduced transparency of the lens and this leads to vision
loss.
3
  Anterior subcapsular cataracts (ASC) are cataracts that involve the formation of
opacities in the epithelial cells following ocular trauma and eye surgery.
4
  They are
characterized by capsular wrinkling, formation of spindle-shaped cells, and the
accumulation of extracellular matrix (ECM).
4, 5
  The formation of this type of cataract
may be associated with abnormal expressions of growth factors within the lens.
Transforming growth factor beta (TGF-!) is a secreted polypeptide that is
involved in various cellular processes, including cell proliferation, differentiation,
apoptosis, migration and ECM formation.
5-9
  TGF-! has been shown to be promote
wound healing by stimulating the production and deposition of ECM, which are essential
to normal tissue repair after injury.
10
  The profibrotic actions of TGF-! have also been
implicated in fibrotic pathogenesis in the eye such as glaucoma and ASC.
4, 11-13
  Past
studies have found that the over expression of active TGF-! proteins in rat lens epithelial
explants and cultured rat and transgenic mice lenses induces the formation of fibrotic




in anterior subcapsular cataract, both alpha smooth muscle actin ("-SMA) and type I
collagen are found in the TGF-!-induced plaques.4   Thus, both "-SMA and type I
collagen have been used as molecular markers to identify capsular plaques that are
associated with subcapsular cataract because these proteins are not usually present under
normal conditions.
14, 17
  Previous in-vitro TGF-! experiments with cultured rat lenses
showed that there are both a gender and an age effect in relation to cataract development
when exposed to TGF-!.17, 18  However, the mechanisms involved in TGF-!-induced
cataract formation are still unclear.
The focus of this dissertation is to explore the potential TGF-! mechanisms
involved in subcapsular cataract development in three different rodent models.  The
morphological and molecular effects of TGF-! were analyzed by use of histology,
immunohistochemistry, Western blot protein analysis, TUNEL assay and optical analysis.
The first chapter examines the optical effects of TGF-!-induced subcapsular cataract
formation in cultured rat lenses using a laser scanning instrument.  The role of matrix
metalloproteinases (MMPs) with respect to TGF-!-induced subcapsular cataract
development was also investigated.  The purpose of the second chapter was to directly
determine the requirement for Smad3 (TGF-! signaling protein) in ASC formation using
an in-vivo transgenic TGF-!1/Smad3 knockout mouse model.  Evidence of ASC
formation in TGF-!1/Smad3-/- (null) mice and their TGF-!1/Smad+/+ (wild-type)
littermates was evaluated histologically using EMT (epithelial-to-mesenchymal
transition) markers which include "-SMA as well as fibronectin, collagen type I and IV
as fibrotic markers.  Formation of ASC in mice was also evaluated using a quantitative
3
measure of lens optical quality.  Finally chapter three used the in-vitro rat lens epithelial
explant model to investigate the effects of heat shock treatment and the role of molecular
chaperones on TGF-!2-induced EMT.  The morphological and molecular changes of the
rat lens epithelial explants were examined.  The expressions of "-SMA, F-actin, and E-
cadherin were used as indicators of EMT.  The protein expression levels of Hsp70, Hsp90
and "A- and "B-crystallin and apoptotic cell loss were also determined.
*Note: The references for general introduction and conclusion is on pg.159
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Chapter 1
The Role of Matrix Metalloproteinases in TGF-!-induced
Anterior Subcapsular Cataract Development
All of the work involved in chapter one was done by Alice Banh. A majority of the data
and results from chapter 1 was published in a manuscript as part of a collaborative effort
with the West-Mays group at McMaster University.  Please refer to Dwivedi et al.
American Journal of Pathology, Vol. 168, No.1, Jan. 2006 (p.69-79).
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1.1 Introduction
The crystalline lens is a transparent structure that provides part of the refractive
power needed to focus images on the retina of the human eye.  The embryonic lens arises
from the primitive head ectoderm overlying the optic vesicle.  The head ectoderm is
stimulated by the optic vesicle to proliferate and thicken into a placode, which eventually
forms a hollow lens vesicle.  The lumen of the vesicle is then filled by growth of the
posterior vesicle cells to form the primary lens fibre cells.  Continued development of the
lens is a result of mitosis of epithelial cells located at the lens equator.
1, 2
  The proliferated
epithelial cells become the secondary fibre cells.  The lens grows throughout life by the
continuous addition of new fibre cell layers on top of older fibres, with minimal protein
turnover.
1
  The cells that form the deeper fibres lose their nuclei and mitochondria.
Therefore, the cells in the lens nucleus were formed during the early phase of embryonic
development and the cells in the cortex are the newest.  It is important that the lens
maintains its native protein organization to function as an optical device.
1, 3
A cataract results in reduced transparency of the ocular lens and this leads to
vision loss.  Many factors such as UV radiation, congenital cataracts, eye injuries and
age-related changes may cause the onset of cataracts.
4
  However, the causes of cataracts
are still not fully understood and there is a need to investigate the molecular mechanisms
that are involved in cataract formation.  Anterior subcapsular cataracts are common
cataracts that involve the formation of opacities in the epithelial cells following ocular
trauma and eye surgery.
5
  They are characterized by capsular wrinkling, formation of
6
spindle-shaped cells, and the accumulation of extracellular matrix (ECM).
5, 6
  The
formation of this type of cataract may be associated with abnormal expressions of growth
factors within the lens.
Transforming growth factors beta (TGF-!) are secreted polypeptides that play
crucial roles in cell proliferation, differentiation, migration and ECM formation in the
lens.  There are three functionally and structurally related species of TGF-!: TGF-!1,
TGF-!2 TGF-!3.6  TGF-! is involved in wound healing processes by promoting the
production and deposition of the extracellular matrix, which is essential to normal tissue
repair after injury.
7
  In normal mature lenses, TGF-! proteins are secreted as inactive
complexes and remain latent.
6
  Interestingly, past studies have found that the over
expression of active TGF-! proteins in rat lens epithelial explants and cultured rat and
transgenic mice lenses induces the formation of fibrotic plaques and morphological
changes similar to those of anterior subcapsular cataracts in human lenses.
5, 6, 8-10
  As in
anterior subcapsular cataract, both alpha smooth muscle actin ("-SMA) and type I
collagen are found in the TGF-!-induced plaques.5  Thus, "-SMA and type I collagen
have been used as molecular markers to identify capsular plaques that are associated with
subcapsular cataract because these proteins are not usually present under normal
conditions.
8, 11
  Previous in-vitro TGF-! experiments with cultured rat lenses showed that
there are both a gender and an age effect in relation to cataract development when
exposed to TGF-!.11, 12  However, the mechanisms involved in TGF-!-induced cataract
formation are still unclear.
7
Matrix metalloproteinases (MMPs) are a family of enzymes that consist of 25
homologues which share many common properties, including a zinc binding region
located at the active site of the enzyme.
13-15
  As in the case of TGF-!, MMPs and tissue
inhibitors of metalloproteinases (TIMPs) are responsible for remodeling and turnover of
extracellular matrices.
14-16
  MMPs are found in many tissues of the eye such as, the
vitreous humour, aqueous humour, retina, cornea, and lens.
17-22
  A previous study
demonstrated that MMPs and TIMPs are expressed in the lens epithelial cells of human
lenses after cataract surgery and during the early phase of capsular healing.
23
Experiments using porcine capsular bags showed that there is an increased expression of
both MMP-2 and MMP-9 in the lens during pathological conditions, such as cataract and
posterior capsule opacification.
24
  MMP-2 and MMP-9 are also involved in the wound
healing process of corneal ulceration in mice.
21
  Cell-surfaced localized MMP-2 and
MMP-9 can activate latent TGF-!.25  On the other hand, an experiment with chicken lens
annular pad cells demonstrated that treatment with TGF-! is required to stimulate
secretion of MMP-2 and MMP-9.
14
  These various findings revealed the complexity of
the relationship between MMPs and TGF-! and further investigation is necessary to
uncover the regulation and activation of MMPs and TGF-! that leads to lens epithelial
opacity.
The purpose of this study is to analyze the optical effects of TGF-!-induced
subcapsular cataract formation in cultured rat lenses using a laser scanning instrument.
Another objective is to investigate the potential role of MMPs with respect to TGF-!-
8
induced subcapsular cataract development.  Thus, Ilomastat (an MMP inhibitor)
treatment is used to examine the inhibitory effect on subcapsular cataract development.
9
1.2 Materials and Methods
Lenses were dissected from two to six month old male Wistar rats after
euthanization with CO2.  The lenses were cultured in specialized serum-free medium
M199 with Earl’s salts and L-glutamine (product number 11150-059, Invitrogen Inc.,
ON. Canada) containing 0.1% bovine serum albumin (A-2058, Sigma, MO. USA), 50
IU/ml penicillin, 50 ug/ml streptomycin and 2.5 ug/ml amphotericin B (Fungizone).
12
Lenses were incubated at 37 °C with 4.0% CO2 for 24 hours before any treatment to
ensure that they were not damaged during the dissection.  The lenses were kept in a
sterile environment to prevent contamination.  A total of 67 lenses were used in this
study.  The lenses were divided into three separate experiments that investigate both the
optical effects of TGF-!2 (product number 302-B2, R&D Systems Inc. MN. USA)
treated lenses and the inhibiting potential of Ilomastat (GM6001, Chemicon International,
CA. USA) on TGF-!2 treated lenses.  In addition to the laser scanner, a digital camera
mounted to a dissecting scope was used to photograph the visual appearance of each lens
as a comparisons to the optical quality measured by the laser scanner.
1.2.1 Experiment 1.  TGF-!2 and Ilomastat Treatment
Lenses (n=20) were obtained as described above and separated into 3 treatment
groups: control (culture medium, n=6), treatment with TGF-!2 (1 ng/ml, n=8), and
treatment with TGF-!2 (1 ng/ml) + Ilomastat (25 µM, n=6).  After 24 hours of initial
incubation, the culture medium was removed and 4 ml of appropriate treatment media
10
was added to the tissue culture plates.  The rat lenses remained in their respective
treatment media for 6 days prior to optical analysis.   The lenses were then transferred to
a specialized glass chamber filled with culture medium to be analyzed with a laser
scanner.
1.2.2 Experiment 2. Concentration Effect of TGF-!2
This experiment was performed to examine the optical changes and subcapsular
cataract formation in rat lenses treated with two different TGF-!2 concentrations: 1 ng/ml
and 2 ng/ml.  A total of 33 lenses were divided into 5 different treatment groups: control
group (culture medium, n=8), TGF-!2 (1 ng/ml, n=4), TGF-!2 (1 ng/ml) + Ilomastat (25
µM, n=4), TGF-!2 (2 ng/ml, n=9), and TGF-!2 (2 ng/ml) + Ilomastat (25 µM, n=8).
Each lens was optically scanned at 4 time points (initial scan prior to treatment, 2, 4, and
6 days after initial treatment) to examine the temporal effects of the treatment.  Each lens
was temporarily removed from the treatment medium during the scanning process and
then replaced back into the appropriate medium and incubated until the following scan
point.  Representative lenses from each group were photographed on each day.
1.2.3 Experiment 3. Effect of Ilomastat Concentration
This study was performed to ensure that the optimal concentration of Ilomastat
was used and that no lens damage is caused by the Ilomastat itself.  Ilomastat is dissolved
in an aqueous solution (containing DMSO), therefore an Ilomastat negative control is
11
used to show that the effect of treatment is not due to the dissolving solution.
Subcapsular cataract development in rat lenses was evaluated in lenses treated with TGF-
!2 (2 ng/ml) in combination with 4 different Ilomastat concentrations (10,15, 20 and 25
µM).  A total of 14 lenses were divided into 8 groups which consisting of: a control
group (with culture medium, n = 2), 25 µM Ilomastat only (n = 1), TGF-!2 (n = 2), TGF-
!2 + Ilomastat negative control (GM6001 negative control, Calbiochem, CA. USA; n =
1), TGF-!2 + 10 µM Ilomastat (n = 2), TGF-!2 + 15 µM Ilomastat (n = 2), TGF-!2 + 20
µM Ilomastat (n = 2), and TGF-!2 + 25 µM Ilomastat (n = 2). Optical analysis was
performed 6 days after initial treatment.  These lenses were treated in the same manner as
described in the above experiments.
1.2.4 Laser Scanning Instrument
The laser scanning system (ScanTox#) consists of a collimated helium neon
(HeNe) laser source (on an X-Y table) that projects a beam onto a mirror mounted at 45 °
on a carriage assembly.  The reflected beam then goes up through the scanner table
surface and through the lens under examination.  Digital cameras capture images of the
light beam refracted by the lens as it scans across it.  The information collected by the
digital cameras is transferred to a computer, and the refracted direction for each of the
beam positions is recorded with respect to the optical center, the point at which the slope
of the laser beam approaches zero.  Each scan involved 20 laser positions across a 3 mm
diameter span with a step size of 0.15 mm.  The measurements made included average
back vertex distance (BVD, a measure of focal length), and back vertex distance
12
variability (BVD error or sharpness of focus) as well as relative transparency (or
scatter).
26-28
  BVD error is the most sensitive measurement in detecting optical changes in
subcapsular cataract development in the rat lens and thus, the results will focus on the
changes in BVD error as an indication of decrease lens optical quality.
1.2.5 Statistical Analysis
The repeated-measures analysis of variance (repeated-measures ANOVA) and the
unpaired student’s t-test (SPSS$ 11.0 statistical software) were used to assess treatment,
concentration, and temporal effects on the back vertex variability.  A probability value
(p-value )% 0.05, indicating a 95% confidence interval, was considered to be significant.
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1.3 Results
The results of this study demonstrate that treatment of cultured rat lenses with
TGF-!2 induces the formation of anterior subcapsular cataracts (Figures 1-4).  The first
experiment studies the optical effects of TGF-!2 (1ng/ml) and the addition of Ilomastat
(25 µM) to TGF-!2 treatment.  Figures 1 and 2 show that TGF-!2-induced subcapsular
cataracts increased the light scattering properties of the lens.  The TGF-!2 treatment
group has a significantly (paired student’s test: p % 0.05) larger BVD error (0.196 ± 0.003
mm) relative to the control lenses (0.101 ± 0.005 mm) and TGF-!2 + Ilomastat (0.110 ±
0.004 mm) groups.  Treatment with Ilomastat (MMP inhibitor) effectively inhibits
subcapsular cataract formation and the lenses show optical measurements that are similar
to those of the control lenses.
Figure 3 shows the appearances of lenses at 0, 2, 4 and 6 days after treatment.
Lenses from the control and TGF-!2 + Ilomastat group remained clear throughout the
experiment, while TGF-!2 treated lenses remained clear up to day 4 with lens opacities
appearing on day 6.  The optical measurements in Figure 4 show the changes in back
vertex variability at the time points described when treated with two different
concentrations of TGF-!2 (1 ng/ml and 2 ng/ml).  Repeated-measures ANOVA of the
BVD error measurements show that there is both a treatment and temporal effect (p %
0.05).   The BVD errors for the control lenses (range from 0.068 ± 0.004 mm to 0.082 ±
0.003 mm) and did not change significantly from day 0 to 6.  Rat lenses treated with
Ilomastat: TGF-!2 1 ng/ml + Ilomastat show BVD errors ranging from 0.078 ± 0.018
14
mm to 0.084 ± 0.001 mm, while those treated with TGF-!2 2 ng/ml + Ilomastat show
errors ranging from 0.071 ± 0.002 mm to 0.079 ± 0.006 mm. The results from both
Ilomastat groups are similar to the values for the control lenses.  Both treatment with 1
ng/ml TGF-!2 (errors ranging from 0.073 ± 0.001 mm to 0.122 ± 0.003 mm) and 2 ng/ml
TGF-!2 (errors ranging from 0.075 ± 0.014 mm to 0.142 ± 0.009 mm) cause a significant
increase in BVD error on day 6.  The TGF-!2 groups (1 ng/ml and 2 ng/ml) also show
significant optical change relative to the control and both Ilomastat groups. However,
there is no significant difference between TGF-!2 (1 ng/ml) and TGF-!2 (2 ng/ml).
Figures 5 and 6 show optical measurements from lenses treated with different
concentrations of Ilomastat: 10 µM (0.332 ± 0.029 mm), 15 µM (0.310 ± 0.029 mm), 20
µM (0.115 ± 0.011 mm) and 25 µM (0.097 mm) in addition to TGF-!2.  The lower
Ilomastat concentrations (10 µM and 15 µM) are unable to prevent subcapsular cataract
development, while lenses treated with the higher concentrations (20 µM and 25 µM) are
as transparent as the control lenses and show similar BVD error (0.085 ± 0.001 mm).
Also treatment with 25 µM Ilomastat (0.108 mm) only had no effect on the lens, while
treatment with the negative control for Ilomastat + TGF-!2 (0.254 mm) demonstrate
similar effects as the TGF-!2 (0.334 ± 0.031 mm) treated lens
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Figure 1. Optical scans of rat lenses
The images above shows the transmittance of the laser source through a control, TGF-!2,
and TGF-!2 + Ilomastat treated rat lens.  The refracted beams through the control lens
and TGF-!2 + Ilomastat lens are focused and relatively straight.  The TGF-!2 treated
lens show increase scatter and the refracted light is less focused then the other lenses.
The scatter plots on the right represents the back vertex distance (focal length
measurements) for the corresponding lens.  Each point on the scatter plot represents the
back vertex distance from each beam location.  Increased variability in the back vertex




Figure 2. TGF-!2 induced subcapsular cataract formation
The top panel (A) are digital photographs representing a control (left), TGF-!2 (center),
and TGF-!2 + Ilomastat (right) lens.  The TGF-!2 treated lens shows subcapsular
plaques while the control lens and TGF-!2 + Ilomastat treated lens remained transparent.
The bar graph (B) shows the back vertex variability measurements (BVD error, mm ±
SEM) for each treatment group.  *Statistical analysis (unpaired student’s t-test: p % 0.05)
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shows that treatment with TGF-!2 (0.196 ± 0.032) significantly increased the BVD error
(decreased sharpness of focus) when compared to the control (0.102 ± 0.005) and TGF-
!2 + Ilomastat (0.110 ± 0.004) groups.
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Figure 3. Rat lenses at different time points
The photographs display the appearance of lenses from each experimental group (control,
TGF-!2 and TGF-!2 + Ilomastat) at days 2, 4, and 6 after initial treatment.   Subcapsular
plaques were found in TGF-!2 lenses at day 6 while the control and TGF-!2 + Ilomastat
treated lenses are clear.  At days 2 and 4 all lenses appear to be similar.
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Figure 4. TGF-! concentration effects
The graph shows the changes in back vertex variability (BVD error, mm ± SEM) from
day 0 (initial measurements prior to treatment) to 2, 4, and 6 days after initial treatment.
Two concentrations of TGF-!2 (1 ng/ml and 2 ng/ml) were used in this experiment.
Repeated-measures analysis of variance demonstrated that there is both a treatment and
temporal effect (p % 0.05).  * + At day 6 after initial treatment both concentrations of
TGF-!2 (1 ng/ml and 2 ng/ml) show significantly higher BVD error measurements than
other treatment groups (control, TGF-!2 (1 ng/ml) + Ilomastat and TGF-!2 (2 ng/ml) +
Ilomastat).  However, there are no significant differences between TGF-!2 (1 ng/ml) and
TGF-!2 (2 ng/ml).  The control, TGF-!2 (1 ng/ml) + Ilomastat and TGF-!2 (2 ng/ml) +
Ilomastat groups did not show significant changes in BVD error.
20
Figure 5. Ilomastat treatment
The pictures demonstrate the effects of TGF-!2 (2 ng/ml) in combination with four
different concentrations of Ilomastat (10 µM, 15 µM, 20 µM and 25µM) in comparisons
to the control (culture medium only) lens.  The lens treated with TGF-!2 + 5 µM
Ilomastat shows distinctive plaques and opacification.  Both TGF-!2 + 10 µM Ilomastat
and TGF-!2 + 15 µM Ilomastat-treated lenses show overall opacities.  The photographs
also show that the control, TGF-!2 + 20 µM Ilomastat and TGF-!2 + 25 µM Ilomastat
lenses are clear.
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Figure 6. Ilomastat inhibition effect
This bar graph represents the back vertex variability (BVD error, mm) of lenses treated
with TGF-!2 (2 ng/ml) alone and with four different concentrations of Ilomastat (10 µM,
15 µM, 20 µM and 25 µM) as well as control lenses (culture medium only), TGF-!2,
negative control of Ilomastat and 25 µM Ilomastat treated lenses.  These measurements
show a decrease in BVD error as the Ilomastat concentration increases to 25 µM.  BVD
errors from lenses treated with 25 µM Ilomastat only, TGF-!2 + 20 µM Ilomastat and
TGF-!2 + 25 µM Ilomastat are not significantly different from the control lenses.  * The
data also show that lenses treated with TGF-!2 only, with negative control Ilomastat +
TGF-!2 and 10, and 15µM Ilomastat + TGF-!2 have BVD errors that are significantly
different from control lenses.
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1.4 Discussion
Anterior subcapsular cataracts are associated with many pathological ocular
conditions such as iritis and atopic dermatitis, as well as chemical and mechanical
trauma.
29
  The development of these cataracts involves epithelial-mesenchymal transition
(EMT).  EMT progression is characterized by the transdifferentiation of lens epithelial
cells into myofibroblastic cells, which causes the accumulation of ECM molecules.
12, 29, 30
TGF-! can induce morphological and molecular changes similar to those of human
anterior subcapsular cataract.
5
   In-vitro rat lens culture and lens epithelial explants have
shown that all three TGF-! isoforms (TGF-!1, TGF-!2 and TGF-!3) can induce
cataractous changes.  However, TGF-!1 is 10 times less potent than TGF-!2 and TGF-
!3.8
TGF-! can promote and inhibit cell growth depending on the cell type.  In general
TGF-! has inhibitory effects on cells of epithelial origin, while it is mitogenic for smooth
muscle and fibroblasts.
31
  This is supported by the increase in expression of "-SMA in
the lens epithelium during subcapsular cataract development.  As mentioned before in the
introduction, "-SMA is not found under normal lens conditions.  TUNEL (TdT-dUTP
terminal nick-end labeling) staining of TGF-!1 transgenic mice lenses and in-vitro




The susceptibility of the lens to TGF-!-induced cataractous changes is dependent
on the number of TGF-! receptors type I and II (T!RI and T!RII) present.29  In contrast
to rat lenses (which have both T!RI and T!RII), prolonged exposure of clear undamaged
human lenses (T!RII only) to TGF-!2 did not induce EMT and "-SMA expression
associated with anterior subcapsular cataract formation.  However, traumatized human
lenses treated with TGF-!2 did show increased in expression of " -SMA and
multilayering of epithelial cells, which could be due to an increased expression of both
T!RI and T!RII.29  It has also been shown that there is increased sensitivity to TGF-!
induction as the age of the rat increases.
12
  Another study proved that estrogen plays a
protective role in female rats against TGF-!-induced cataracts.32  TGF-!  has been
detected endogenously within the lens cells as well as in the aqueous and vitreous
humors.  TGF-! modified ECM by inducing the expression of MMPs and other enzymes
involved in matrix remodeling.
14
This study focuses on the optical changes in rat lenses treated with TGF-!2.
TGF-!2 effectively induced the formation of anterior subcapsular cataracts in rat lenses
as shown in previous studies.
8, 9
  A laser scanning instrument was used to objectively
measure the back vertex variability (BVD error) in the lenses.  As shown in the results,
TGF-!2 (1 ng/ml and 2 ng/ml) treated lenses show significantly larger BVD errors
(decreased sharpness of focus) relative to the BVD errors of the control lenses. However,
there are no significant differences between the 1 ng/ml TGF-!2 lenses and 2 ng/ml TGF-
!2 lenses.  The higher concentration of TGF-!2 (2 ng/ml) demonstrated a greater change
in BVD errors, compared to all other treatment groups at day 6 after initial treatment.
24
An MMP inhibitor (Ilomastat) was also used in this experiment to investigate the
role of MMPs in TGF-!-induced subcapsular cataract development.  Through the
breakdown and remodeling of extracellular matrix, MMPs play an essential role in
normal physiological processes such as embryonic development, morphogenesis,
reproduction, and tissue resorption and remodeling.
33
  MMPs are secreted as inactive
zymogens (pro-MMPs) and require proteolytic removal of an amino-terminal pro-
sequence for them to function.
15
  Various growth factors, hormones, cytokines, cell-to-
matrix, cell-to-cell interactions and cellular transformation transcriptionally regulate
MMP expression.
16, 33
  It has been suggested that over-expression of MMPs can promote
tumor invasion and angiogenesis.
25
  Interestingly, MMP2 (gelatinase A, 72 kD) and
MMP9 (gelatinase B, 92 kD) are the most widely studied members of the MMP family in
the eye.
14, 20
  Both MMP2 and MMP9 are up-regulated during abnormal ocular conditions
such as posterior capsule opacification, proliferative diabetic retinopathy and epithelial
wound healing.
19, 23, 24, 34
  The expression of MMP2 and MMP9 is both positively and
negatively regulated by TGF-!.14
The results from this experiment show that prolonged exposure (6 days) of
cultured rat lenses to TGF-!2 plus 25 µM Ilomastat effectively inhibited the formation of
subcapsular plaques and lens opacities.  Optical analysis demonstrated that there are no
significant differences in BVD errors between the TGF-!2 + 25 µM Ilomastat-treated
lenses and control lenses.  Also the treatment with Ilomastat significantly reduced the
effects of TGF-!2 on cultured rat lenses, as shown in the optical results.  This is the first
25
experiment that used cultured rat lenses to investigate the inhibitory effects of Ilomastat
on subcapsular cataract development.  Ilomastat is a general MMP inhibitor that has been
shown to prevent lens capsule contraction, and human lens and corneal epithelial cell
migration.
22, 35
  However, the mechanisms that are involved in subcapsular cataract
formation with respect to the relationship between MMPs and TGF-! are still not fully
understood.
In conclusion, this study has demonstrated that the cultured rat lens model can be
used to investigate the role of TGF-! and MMP involvement in anterior subcapsular
cataract development.  Further studies will provide more insight as to the specific MMPs
involved in this process.  Also in-vivo transgenic mice models can be use to verify the
results of the in-vitro rat lens culture model.
26
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Transforming growth factor beta (TGF-!) is a secreted polypeptide that is
involved in various cellular processes, including cell proliferation, differentiation,
apoptosis, migration and extracellular matrix (ECM) formation.
1-5
  TGF-! has been
shown to promote wound healing by stimulating the production and deposition of ECM,
which are essential to normal tissue repair after injury.
6
  The profibrotic actions of TGF-!
have also been implicated in fibrotic pathogenesis in the eye such as glaucoma and
anterior subcapsular cataracts (ASC).
7-10
The ocular lens is a transparent structure that provides part of the refractive power
needed to focus images on the retina of the human eye.  A cataract involves a reduction in
transparency of the lens, which can lead to vision loss.  Specifically, ASC can occur
following ocular trauma, ocular surgery or in conjunction with diseases like atopic
dermatitis and retinitis pigmentosa.
11, 12
  The development of ASC involves the
transformation and proliferation of the anterior epithelial cells of the lens into plaques of
large "spindle shaped" cells, or myofibroblasts, through a phenomenon known as
epithelial-to-mesenchymal transition (EMT).
13-15
  The appearance of the myofibroblasts
promotes lens capsule wrinkling and an aberrant deposition of extracellular matrix
(ECM), both of which are features of ASC.
1, 7, 16, 17
  Similarly, in secondary cataract (also
known as posterior capsular opacification (PCO)), a complication that develops after
cataract surgery, lens epithelial cells that remain within the capsule are triggered to
33
proliferate and migrate to the posterior lens capsule where they transition into
myofibroblasts through EMT.
18, 19
Under physiological conditions, TGF-! in the lens and ocular media mainly exists
in its latent form, whereas biologically active TGF-! has been detected in the ocular
media from patients suffering with ASC.
20, 21
  There are three functionally and
structurally related species of TGF-!: TGF-!1, TGF-!2 and TGF-!3.22  Studies using in-
vitro rat lens cultures and lens epithelial explants have shown that all three TGF-!
isoforms can induce cataractous changes similar to those observed in humans. However,
TGF-!1 is 10 times less potent than TGF-!2 and TGF-!.23  The in-vivo expression of
self-activating TGF-!1 in a transgenic mouse model has been useful for examining the
morphological and molecular changes involved in ASC formation, which closely
resemble human ASCs.
1, 7, 24
  However, the TGF-!-mediated signaling pathways
regulating fibrosis including those governing ASC formation have not been clearly
defined.
Smad proteins are intracellular molecules involved in TGF-! signal transduction
from the receptors to the target genes in the nucleus.
22, 25, 26
  Upon ligand binding and
TGF-! receptor activation, phosphorylation of receptor-regulated Smad2 and Smad3
occurs, which leads to the formation of hetero-oligomeric complexes with Smad4 (Co-
Smad).
22, 25, 26
  The Smad complexes then translocate into the nucleus, where they
regulate target gene expression in collaboration with other coactivators and corepressors.
The Smad3 knockout mouse model has been useful for determining TGF-!-mediated
34
fibrotic events requiring Smad3 signaling.
27-30
  Importantly, ablation of Smad3 in mice
was also shown to prevent the EMT of lens epithelial cells that occurs upon injury to the
lens capsule 
31
, suggesting that EMT in the lens may be entirely Smad3-dependent.
However, the effect of TGF-! on ASC formation in the absence of Smad3 has not been
directly tested.
In the current study we directly determined the requirement for Smad3 in ASC
formation using an in-vivo transgenic TGF-!1/Smad3 knockout mouse model.  Evidence
of ASC formation in TGF-!1/Smad3-/- mice and their TGF-!1/Smad wild-type
littermates was evaluated histologically using a EMT marker such as "-SMA as well as
fibronectin, collagen type I and IV as fibrotic markers.  Formation of ASC in mice was
also evaluated using a quantitative measure of lens optical quality.  The results show that
EMT and the formation ASC plaques occurs in the TGF-!1/Smad3-/- mice, accompanied
by a significant decrease in optical quality of the lens.  However, the plaques in the TGF-
!1/Smad3-/- mice were smaller, contained a greater number of apoptotic cells and
substantially less collagen compared to their Smad3 heterozygote and wild-type
littermates.  Together these findings demonstrate that while Smad3 signaling contributes
to TGF-!1-induced ASC formation, it is not necessary and additional Smad3-
independent pathways are involved in this ocular fibrotic disease.
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2.2 Materials and Methods
2.2.1 Generation of transgenic TGF-!1/Smad3 knockout mice
All animal studies were carried out according to the Canadian Council on Animal
Care Guidelines and the Association for Research in Vision and Ophthalmology (ARVO)
Statement for the Use of Animals in Ophthalmic and Vision Research.  The transgenic
TGF-!1 mice contain a human TGF-!1 cDNA construct with an "A-crystallin promoter
designed for lens specific expression of active TGF-! 1 1 on a FVB/N/C57BL/6J
background.  The Smad3 null mutant was generated by the deletion of exon 8 of the
Smad3 gene, which truncated 89 amino acids from the C-terminal end.
32
  Exon 8 contains
an SSVS consensus phosphorylation site and an L3 loop which are essential for
interaction with the TGF-! receptor 2.  TGF-!1 transgenic mice were bred with Smad3
null and heterozygous mice on a SvEv/C57BL background to generate mice with the
following genotypes: TGF-!1/Smad3-/- (null), TGF-!1/Smad3+/- (heterozygous), TGF-
!1/Smad3+/+, Smad3-/- and non-transgenic/Smad+/+ (wild-type).  Wild-type littermates




DNA extraction and purification from mouse ear tissue was performed using the
Qiagen DNeasy tissue kit (Qiagen Inc.,On. Canada).  Genotypes were determined by
polymerase chain reaction (PCR) analysis.  The TGF-!1 transgene was identified by
using primers specific for the simian virus 40 (SV40) sequences in the transgene: the
sense primer (5&-GTGAAGGAACCTTACTTCTGTGGTG-3&) and the antisense primer
(5&-GTCCTTGGGGTCTTCTACCTTTCTC-3&) yield a 300 bp fragment in the PCR
reactions 
33
.  PCR reactions were carried out for 36 cycles using the following conditions:
initial heating for 3 minutes at 94°C (only for cycle 1); denaturation for 30 seconds at
94°C; annealing for 1 minute at 57°C; and extension for 1 minute at 72°C.  A final
extension was carried out for 2 minutes at 72°C.  Agarose gel electrophoresis (1.5%
agarose) with ethidium bromide (EtBr) detection was used to visualize the PCR reaction
products.
The Smad3 wild-type and knockout alleles were detected using three primers.
The Smad3 wild-type allele is detected by using primer 1 (5&-
CCACTTCATTGCCATATGCCCTG-3&)  a n d  p r i m e r  2  ( 5&-
CCCGAACAGTTGGATTCACACA-3&).  Primer 1 (located 5& to the deletion) and
primer 2 (located within the deletion) amplify a 400 bp fragment from wild-type and
heterozygous knockout mice.
32
  The Smad3 knockout allele was detected by using primer
1 and primer 3 (5&CCAGACTGCCTTGGGAAAAGC-3& (located in the pLoxpneo)) to




  PCR reactions were carried out for 31 cycles using the
following conditions: initial heating for 2 minutes at 94°C (only for cycle 1); denaturation
for 30 seconds at 94°C; annealing for 30 seconds at 60°C; and extension for 2 minutes at
72°C.  A final extension was carried out for 2 minutes at 72°C.  A 2% agarose gel
electrophoresis with EtBr detection was used to visualize the PCR reaction products.
2.2.3 Histology and immunohistochemistry staining
Whole eyes were dissected from 2-3 month old mice of each genotype and fixed
in 10% neutral formalin buffer for 24 hours, then dehydrated, processed and embedded in
paraffin.  Paraffin sections of 5 µm thickness were used for either Hematoxylin and Eosin
(H&E), Mason’s Trichrome (collagen deposition), or immunohistochemistry staining ("-
SMA, fibronectin and !-crystallin).  Fresh eyes from each genotype were also embedded
in OCT and frozen sections (5 µm thickness) were used to stain for collagen type I and
IV.  Staining was visualized with a Leica microscope equipped with an
immunofluorescence attachment and images were captured using a high-resolution
camera and associated software (OpenLab; Quorum Technologies). Images were
reproduced for publication using Adobe Photoshop 9.0.1 (Adobe Systems Incorporated).
For " -SMA, fibronectin, and !-crystallin immunoflourescence localization,
paraffin sections were deparaffinized, rehydrated and incubated with 5% normal goat
serum for 20 minutes at room temperature.  The sections were then incubated either with
mouse anti-"-SMA monoclonal antibody (1:100; Sigma-Aldrich Inc., MO. USA), rabbit
38
anti-mouse fibronectin (1:500; Cedarlane Laboratories Ltd., ON Canada) or rabbit anti-!-
crystallin (1:200; donation from J. Samuel Zigler, National Eye Institute) at room
temperature for 1 hour.  The bound primary antibodies were visualized with either a
fluorescein-isothiocyanate (FITC) conjugated goat anti-mouse secondary antibody, goat
anti-rabbit FITC secondary antibody or tetramethyl rhodamine isothiocyanate (TRITC)
conjugated goat anti-rabbit secondary antibody (Jackson ImmunoResearch Laboratories
Inc., PA. USA).  All sections were mounted in Vectashield mounting medium with 4’,6-
Diaminodino-2-Phenylindol (DAPI, Vector Laboratories Inc., CA. USA) to visualize the
nuclei.
Frozen tissue sections were thawed at room temperature, fixed with acetone for
20 minutes at –20 °C and used for immunofluorescence localization of collagen type I or
IV. The sections were incubated with 5% normal goat serum for 20 minutes at room
temperature followed by rabbit anti-collagen type I, or rabbit anti-collagen type IV
primary antibody (1:100; Cortex Biochem, CA. USA) at room temperature for 1 hour.  A
goat anti-rabbit FITC secondary antibody was used to visualize the bound primary
antibodies.  All sections were mounted in Vectashield mounting medium with DAPI and
photographed as mentioned above.
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2.2.4 TUNEL assay
TUNEL (terminal deoxynucleotidyl transferase mediated dUTP nick end labeling)
labeling was used to examine cell death in the lens epithelium of each genotype.  Paraffin
sections were deparaffinized and the ApopTag plus flourescein in-situ apoptosis detection
kit (Chemicon International Inc., CA. USA) was used to detect apoptotic nuclei.  The
TUNEL procedure was carried out in accordance with the manufacturer’s instructions.  A
positive control was prepared by treating a sample with DNaseI prior to TUNEL staining.
All sections were mounted in Vectashield mounting medium with DAPI and
photographed as mentioned above.  For quantitative analysis, the percentage of TUNEL-
positive cells among 150 lens epithelial cells in three fields per slide was determined at
400-fold magnification in three different samples from each genotype.
2.2.5 Western blot analysis
Four lenses from each genotype including TGF-!1/Smad3-/-, TGF-!1/Smad3+/-,
TGF-!1/Smad3+/+, Smad3-/- and wild-type mice were collected and pooled for Western
blot analysis of phosphorylated Smad3 (pSmad3) protein expression.  In addition two
lenses from each genotype were collected and pooled for Western blot analysis of "-
SMA protein expression.  The lenses were homogenized in Triton-X100 lysis buffer
containing protease inhibitor cocktail (Roche Applied Science, IN. USA).  The total
protein concentration was determined by the Bradford protein assay 
34
.  Equal amounts of
40
total protein from each group of lenses were electrophoresed on 10% tris-tricine
polyacrylamide gel (pSmad3) or 10% SDS polyacrylamide gel ("-SMA).  The proteins
were electro-transferred onto a nitrocellulose membrane (Pall Corporation, NY. USA).
Membranes were blocked with 5% skimmed milk powder in Tris-buffered saline (50mM
Tris base, NaCl pH 8.5) + 0.1% Tween-20 and then incubated overnight at 4°C with
either a rabbit anti-phospho-Smad3/Smad1 antibody (1:1000; Cell Signaling Inc., MA.
USA) or mouse anti-"-SMA monoclonal antibody (1:1000).  Following this incubation,
membranes were probed with the appropriate HRP-conjugated anti-rabbit or anti-mouse
secondary antibodies (1:5000; Amersham Biosciences, NJ. USA) and ECL detection
reagents (Amersham Biosciences, NJ. USA).  The Western blots were visualized by x-ray
film exposure.  The "-SMA membranes were stripped and reprobed with mouse anti-!-
actin antibody (1:1000; Cedarlane Laboratories Ltd., On Canada) as a loading control.
The secondary detection for !-actin followed the same procedures as mentioned above.
2.2.6 Optical analysis
Lenses were dissected from 2-3 month old mice after euthanization with CO2.
The lenses were cultured in specialized serum-free medium M199 with Earl’s salts and
L-glutamine (product no. 11150-059, Invitrogen Inc., ON. Canada) containing
penicillin/streptomycin. Lenses were incubated at 37°C with 4.0% CO2 for 24 hours prior
to optical analysis to ensure that no damage occurred during the dissection.  A total of 33
lenses were used for optical measurements: TGF-!1/Smad3-/- (n = 8), TGF-!1/Smad3+/-
(n = 8), TGF-!1/Smad3+/+ (n = 11) and wild-type (n = 6) lenses.  A laser scanning system
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(ScanTox#) developed at the University of Waterloo, was used to analyze the quality of
the lenses 
35-37
.  The laser scanner consists of a collimated helium neon (HeNe) laser
source (on an X-Y table) that projects a beam onto a mirror mounted at 45 ° on a carriage
assembly.  The reflected beam then goes up through the scanner table surface and
through the lens under examination.  There are two digital cameras that capture images of
the light beam being through the lens.  The image information collected by the digital
cameras is transferred to a computer, and the refracted direction for each of the beam
positions is recorded with respect to the optical center, the point at which the slope of the
laser beam approached zero.
35-37
  Each scan involved 20 laser positions across a 2 mm
diameter with a step size of 0.10 mm.  The measurements made included average back
vertex distance (BVD, a measure of focal length), and back vertex distance variability
(BVD error or sharpness of focus) and relative transparency (or scatter).  The BVD error
is the most sensitive measurement in detecting optical changes in subcapsular cataract
development in the mouse lens.  Thus, the results will focus on the changes in BVD error
as an indication of decreased optical quality in the lens.
2.2.7 Statistical analysis
The analysis of variance (ANOVA; SPSS$ 11.0 statistical software) was used to
assess the optical effects (back vertex variability) of cataract formation between each
group of mouse lenses.  The unpaired student’s t-test was used to analyze the apoptotic
cell counts for the TUNEL assay.  A p-value % 0.05 was considered to be significant with
a 95% confidence interval.
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2.3 Results
2.3.1 Generation of transgenic TGF-!1/Smad3 KO mice
Figure 1 represents the PCR results for 2-3 month old offspring generated from
crosses between the Smad3
+/-
 and TGF-!1 transgenic mice.  The genotype of the mice
was determined based on detection of the TGF-!1 transgene (300 bp) (top gel) and the
Smad3 wild-type (400bp) and Smad3 knockout (250bp) alleles (bottom gel).  TGF-
!1/Smad3+/- mice show all three bands (lane 3) while TGF-!1/Smad3-/- and TGF-
!1/Smad3+/+ mice exhibit 2 bands, the transgene and either the wild-type allele or the





exhibit a single band at 400 and 250bp respectively (lanes 1 and 5).
Western blot analysis for phosphorylated Smad3 provides verification that Smad3
signaling is absent in the lenses of Smad3 knockout mice (Fig. 2).  The antibody used for
pSmad3 (Ser433/435) detection cross reacts with pSmad1 (Ser463/465; 65 kDa) which
was detected in all lenses examined and thus acted as a positive internal control.  Both the
TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- lenses exhibited pSmad3 (58 kDa) in contrast to
the non-transgenic wild-type and Smad3
-/-
 lenses, which did not.  p-Smad1 expression
was also increased in the TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- lenses.  Smad1 is a
mediator activated mainly by BMP (bone morphogenetic protein) receptors.
38, 39
Interestingly, extracellular signal-regulated kinases (ERK) have been shown to
phosphorylate Smad1 at the linker region, preventing the transcriptional activation by
43
BMP in R-1B/L17 cells.
39
  Thus, the increase in pSmad1 observed in our western may be
due to TGF-!-induced mitogen activated protein kinases (MAPK) signaling.
Importantly, even in the presence of the TGF-!1 transgene, Smad3-/- mice did not show
any detectable pSmad3.  Therefore the deletion of exon 8 of the Smad3 gene completely
inhibited TGF-!1-mediated Smad3 phosphorylation in the lens.
2.3.2 Histological and immunohistochemical analyses of the TGF-!1/Smad3 lenses
Histological examination of eyes from 3 month old TGF-!1 transgenic mice on
all three Smad3 backgrounds (TGF-!1/Smad3+/+, TGF-!1/Smad3-/- and TGF-!1/Smad3+/-
(latter not shown) revealed distinct evidence of ASC formation including extensive multi-
layering of cells forming plaques beneath the anterior lens capsule (Fig. 3).  In contrast to
the cataracts of TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- mice, which typically spanned
nearly the full width of the anterior region of the lens, the subcapsular plaques in the
TGF-!1/Smad3-/- lenses were substantially smaller.  In addition, cells in the Smad3-
deficient plaques exhibited a more rounded appearance than their wild-type and
heterozygote littermates (Compare Fig. 3 J, K).  In addition to lens plaque formation,
TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- (latter not shown) mice exhibited overt defects
in the cornea including increased thickness and cellularity of the corneal stroma that often
resulted in the corneal endothelium adhering to the lens capsule (Fig. 3 B, F).  The
corneal phenotype in the TGF-!1/Smad3-/- mice was much less severe and the cornea did
not come into contact with the lens.  Finally, vacuole formation and nucleation in the
posterior cortex of the mature TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- lenses was
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observed, while these features were substantially reduced or absent in the TGF-
!1/Smad3-/- lenses (Fig. 4).
The expression of "-SMA was examined since this is a commonly used marker
for the EMT that occurs in TGF-!-induced ASC formation (Fig. 5).  Expression of "-
SMA was observed in the subcapsular plaques of the TGF-!1/Smad3+/+, and TGF-
!1/Smad3+/- (latter not shown) lenses whereas no "-SMA expression was detected in the
non-transgenic wild-type and Smad3
-/- 
lenses (Fig. 5).  Importantly, "-SMA expression
was also detected in the plaques of lenses from the TGF-!1/Smad3-/- mice, although
immunoreactivity appeared reduced as compared to the mice with Smad3 wild-type or
heterozygote backgrounds. Staining in the iris of the non-transgenic wild-type and
Smad3
-/- 
served as a positive control for "-SMA expression. Results from western blot
analysis of "-SMA (42 kDa) expression in lens extracts (Fig. 6) confirmed the
immunostaining results.  While all TGF-!1 transgenic mice exhibit distinct expression of
"-SMA, lenses from TGF!1/Smad3-/- mice show reduced levels compared to the TGF-
!1/Smad3+/+ and TGF-!1/Smad3+/- mice. !-actin (42 kDa) protein was used as loading
control and showed equal levels of expression in all samples examined.
Fibronectin is a fibrotic marker known to be expressed in ASC plaques.
40-43
  We
therefore examined the expression of fibronectin in the TGF-!1/Smad3 lenses.  Unlike
non-TGF-!1 transgenic mice where fibronectin expression was found to be confined to
the lens capsule, the cells within the subcapsular plaques of the TGF-!1/Smad3+/+, TGF-
!1/Smad3-/- and TGF-!1/Smad3+/- (not shown) lenses exhibited immunoreactivity to
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fibronectin (Fig.7).  However, as was shown earlier for "-SMA, the intensity of the
immunoreactivity to fibronectin in the cells of the subcapsular plaques of TGF-
!1/Smad3-/- lenses was reduced when compared to the TGF-!1/Smad3+/+ and TGF-
!1/Smad3+/- lenses.
Mason’s Trichrome stain was next used to observe total collagen deposition
(collagen stains blue or aqua) in the mouse lenses (Fig. 8).  In the normal lens, collagen
expression is confined to the lens capsule, whereas aberrant collagen deposition has been
observed in ASC plaques.
43
  The expression of the TGF-!1 transgene resulted in
substantial collagen deposition in the plaques of TGF-!1/Smad3+/+ and TGF-!1/Smad3+/-
(latter not shown) mice as previously reported.
1, 7
  In contrast, much less collagen
deposition was observed in the subcapsular plaques of the TGF-!1/Smad3-/- mice.
Further analysis of collagen type I and IV expression was performed using specific
antibodies (Fig. 9 and 10), since these isoforms are known to be expressed in ASC.
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Expression of collagen type I was detected in the subcapsular plaques of all the
transgenics including TGF-!1/Smad3+/+, TGF-!1/Smad3-/- and TGF-!1/Smad3+/- (latter
not shown) (Fig. 9), whereas non-TGF-!1 transgenic lenses showed no expression of
collagen type I.  Interestingly, the intensity of immunoreactivity for type I collagen was
similar for all the TGF-!1/Smad3-/-, TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- (latter not
shown) lenses. Normal expression of type IV collagen was observed in the lens capsule
of all mice examined 
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 (Fig. 10).  A substantial level of collagen type IV
immunoreactivity in the subcapsular plaques of TGF-!1/Smad3+/+ and TGF-!1/Smad3+/-
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(latter not shown) lenses was observed. In contrast, the plaques of TGF-!1/Smad3-/- mice
exhibited little to no type IV collagen staining.
Previous studies have shown that TGF-!-induced subcapsular plaques consist of a
heterogeneous population of cells that are either immunoreactive to a-SMA or to !-
crystallin, a lens fibre specific marker.
45
  Expression of !-crystallin was therefore
examined to further characterize the cellular makeup of the plaques in the TGF-b1
transgenic lenses (Fig. 11).   Expression of !-crystallin was detected in the posterior part
of subcapsular plaques (away from the lens capsule) in the TGF-!1/Smad3+/+, and TGF-
!1/Smad3+/- (latter not shown) lenses.  These results correspond to the !-crystallin
immunoreactivity in previously detected in larger human ASC plaques.
45
  Interestingly,
the TGF-!1/Smad3-/- lenses also exhibited immunoreactivity to ! -crystallin
demonstrating that although these plaques are reduced in size they still contain a
heterogeneous population of cells similar to their wild-type and heterozygote littermates.
2.3.3 Apoptotic cell death analyses of TGF-!1/Smad3 lenses
Since the ASC plaques observed in the TGF-!1/Smad3-/- mice are smaller than
their wild-type littermates and apoptosis has been reported to occur in TGF-!-induced
ASC, 
8, 46
 we utilized TUNEL labeling to examine the level of apoptosis in the different
experimental groups.  Both the non-transgenic wild-type and Smad3 null lenses did not
exhibit TUNEL-positive nuclei (not shown).  TUNEL-positive nuclei were found in the
subcapsular plaques of all the TGF-! transgenic mice including the TGF-!1/Smad3+/+,
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TGF-!1/Smad3+/- (latter not shown) and TGF-!1/Smad3-/- mice (Fig. 12).  Importantly,
TGF-!1/Smad3-/- lenses demonstrate a significantly higher percentage of TUNEL-
positive cells (20.3±5.8%) as compared to the TGF-!1/Smad3+/+ (6.1±1.1 %) lenses
(unpaired student’s t-test: p % 0.05).  The TUNEL positive cells of TGF-!1/Smad3-/-
lenses are mainly situated at the posterior aspect of the plaque, abutting the lens fibre cell
mass.
2.3.4 Effect of the TGF-!1 and Smad3 on the optical quality of the mouse lens
A laser scanning system was next employed to determine quantitative differences
in the optical quality of the lenses of TGF-!1 transgenic mice on the different Smad3
backgrounds.  As described in detail in the methods, the automated laser scanning system
consists of a scanning helium-neon laser source, which is projected through the lens to
measure lens optical qualities (the average back vertex distance, BVD) and sharpness of
focus (BVD error).
35-37
  The bar graph in figure 13 represents the back vertex distance
variability (BVD error, mm ± SEM) for wild-type, TGF-!1/Smad3+/+, TGF-!1/Smad3+/-,
and TGF-!1/Smad3-/- mouse lenses.  An increase in BVD error signifies a decrease in
sharpness of light focus through the lens.  The TGF-!1/Smad3+/+ and TGF-!1/Smad3+/-
lenses showed the most significant (ANOVA: p % 0.05) BVD errors (0.531±0.071 mm
and 0.486 ±0.040 mm respectively) when compared to wild-type (0.067±0.002 mm)
lenses, indicating that lens optical quality was reduced in the presence of subcapsular
plaques in the TGF-!1 transgenic mice.  The TGF-!1/Smad3-/- (0.099±0.005 mm) lenses
also showed a significantly greater BVD error when compared to the wild-type lenses,
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however, this was significantly lower than the TGF-!1/Smad3+/+ and TGF-!1/Smad3+/-
lenses.  Thus, the optical results correspond with the morphological findings.
49
Figure 1.  Genotyping for TGF-!1/Smad3 KO mice
The top gel shows PCR results for the TGF-!1 (300 bp) transgene, while the bottom gel
shows PCR results for the Smad3 wild-type (Wt, 400b bp) and Smad3 knockout (KO,
250 bp) alleles. The mice have the following genotypes: wild-type (lane 1), TGF-
!1/Smad3-/- (lane 2), TGF-!1/Smad3+/- (lane 3), TGF-!1/Smad3+/+ (lane 4) and Smad3-/-
(lane 5).
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Figure 2. Phosphorylated Smad3
Western blot analysis using an anti-pSmad3/Smad1 antibody for the detection of pSmad3
(58 kDa) protein expression in lens extracts.  The antibody cross reacts with
phosphorylated Smad1 (65 kDa) protein, which served as an internal positive control.
The lanes show the level of phospho-Smad3 protein in TGF-!1/Smad3+/+ (lane 1), wild-
type (lane 2), TGF!1/Smad3-/- (lane 3), Smad3-/- (lane 4) and TGF-!1/Smad3+/- (lane 5)
mouse lenses.  Both TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- lenses show the presence of
pSmad3, whereas wild-type and Smad3 null (TGF-!1/Smad3-/- and Smad3-/-) lenses did
not.
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Figure 3. Histological analysis of the TGF-!1/Smad3 lenses





H and L,) lenses are shown.  The boxes show the areas of
magnification.  The expression of the TGF-!1 transgene induced subcapsular plaque
formation in the TGF-!1/Smad3+/+ and TGF-!1/Smad3-/- lenses (F, G, small arrows).
The subcapsular plaques in TGF-!1/Smad3-/- lenses were smaller than those in the TGF-
!1/Smad3+/+ lenses.  Both the wild-type and Smad3-/- lenses show normal morphology of
the lens epithelium.  The scale bars represent 400 µm (A-D), 100 µm (E-H) and 50 µm
(I-L) respectively.
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Figure 4. Vacuole formation in the TGF-!1/Smad3 lenses
The posterior lens cortex of wild-type (A), TGF-!1/Smad3+/+ (B) and TGF-!1/Smad3-/-
(C) lenses are shown.  The expression of TGF-!1 induced nucleation and vacuole
formation in the TGF-!1/Smad3+/+ lenses. Both the wild-type and TGF-!/Smad3-/- lenses
show normal morphology of the posterior lens cortex.  Scale bar represents 200 µm.
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Figure 5.  Immunohistochemical analysis of "-smooth muscle actin expression (FITC)
Wild-type (A), Smad3
-/- 
(B), TGF-!1/Smad3+/+ (C and E) and TGF-!1/Smad3-/- (D and F)
lenses are shown.  The arrows (red) indicate the subcapsular plaques.  Expression of "-
smooth muscle actin ("-SMA) was detected in the subcapsular plaques of the TGF-
!1/Smad3+/+ and TGF-!1/Smad3-/- lenses.  However, there was less " -SMA
immunoreactivity detected in TGF-!1/Smad3-/- lenses.  Both the wild-type and Smad3-/-
54
lenses show no expression of "-SMA in the lens and normal expression in the iris
(positive control).  The scale bars represent 100 µm (A-D) and 50 µm (E and F).
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Figure 6. "-Smooth muscle actin protein expression
Western blot analysis using an anti-"-smooth muscle actin ("-SMA) antibody for the
detection of "-SMA (42 kDa) protein expression in lens extracts.  The membrane was
stripped and reprobed for !-actin, which served as a loading control.  Lanes 1-5 show "-
SMA and !-actin protein expression in wild-type, Smad3-/-, TGF-!1/Smad3+/-, TGF-
!1/Smad3+/+, and TGF!1/Smad3-/- lenses respectively.  The !-actin signal shows that
equal amounts of protein were loaded in all lanes.  TGF-!1/Smad3+/+, TGF-!1/Smad3+/-
and TGF!1/Smad3-/- lenses show expression of "-SMA, whereas wild-type and Smad3-/-
lenses do not.  The TGF!1/Smad3-/- lenses show reduced levels of "-SMA compared to
both the TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- lenses.
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Figure 7. Immunohistochemical analysis of fibronectin expression (TRITC)
Wild-type (A), Smad3
-/- 
(B), TGF-!1/Smad3+/+ (C and E) and TGF-!1/Smad3-/- (D and F)
lenses are shown.  The arrows (yellow) indicate location of subcapsular plaques.  There
was detectable expression of fibronectin in the subcapsular plaques of the TGF-
!1/Smad3+/+ and TGF-!1/Smad3-/- lenses.  The intensity of fibronectin immunoreactivty
in the subcapsular plaques of TGF-!1/Smad3-/- lenses was reduced when compared to the
TGF-!1/Smad3+/+ lenses.  Both the wild-type and Smad3-/- lenses showed normal
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expression of fibronectin in the lens capsule.  The scale bars represents 100 µm (A-D)
and 50 µm (E and F).
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Figure 8. Mason’s Trichrome staining for collagen
Wild-type (A), Smad3
-/- 
(B), TGF-!1/Smad3+/+ (C and E) and TGF-!1/Smad3-/- (D and F)
lenses are shown.  The arrows (black) indicate location of subcapsular plaques and *
asterisks indicate collagen expression in the lens capsules.  The expression of TGF-!1
increased collagen formation in the TGF-!1/Smad3+/+ and TGF-!1/Smad3-/- lens
epithelium.  However, the collagen deposition in the subcapsular plaques of TGF-
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!1/Smad3-/- lenses was substantially reduced as compared to the TGF-!1/Smad3+/+
lenses.  Both the wild-type and Smad3
-/- 
lenses showed normal collagen expression in the
lens capsule.  The scale bars represent 100 µm (A-D) and 50 µm (E and F).
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Figure 9. Immunohistochemical analysis of collagen type I expression (FITC)
Wild-type (A), Smad3
-/- 
(B), TGF-!1/Smad3+/+ (C and E) and TGF-!1/Smad3-/- (D and F)
lenses are shown.  The arrows (yellow) indicate location of subcapsular plaques.
Expression of collagen type I was detected in the subcapsular plaques of the TGF-
!1/Smad3+/+and TGF-!1/Smad3-/- lenses.  There was no observable difference in
collagen I expression between the TGF-!1/Smad3-/- and TGF-!1/Smad3+/+ lenses.  Both
the wild-type and Smad3
-/- 
lenses show no expression of collagen type I in the lens.  The
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scale bars represents 100 µm (A-D) and 50 µm (E and F).
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Figure 10. Immunohistochemical analysis of collagen type IV expression (FITC)
Wild-type (A), Smad3
-/- 
(B), TGF-!1/Smad3+/+ (C and E) and TGF-!1/Smad3-/- (D and F)
lenses are shown.  The arrows (yellow) indicate the location of subcapsular plaques.
Expression of collagen type IV was detected in the subcapsular plaques of the TGF-
!1/Smad3+/+ and TGF-!1/Smad3-/- lenses.  There was considerable reduction in collagen
IV immunoreactivity in the TGF-!1/Smad3-/- lenses when compared to the TGF-
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!1/Smad3+/+ lenses.  Both the wild-type and Smad3-/- lenses show collagen type IV
present in the lens capsule.  The scale bars represent 100 µm (A-D) and 50 µm (E and F).
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Figure 11. Immunohistochemical analysis of !-crystallin expression (FITC)
The photographs represents: a wild-type (A), Smad3
-/- 
(B), TGF-!1/Smad3+/+ (C and E)
and a TGF-!1/Smad3-/- (D and F) mouse lens.  The arrows (yellow) indicate location of
subcapsular plaques. Expression of !-crystallin was detected in the posterior aspect
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(abutting the lens fibre cell mass) of the subcapsular plaques in both the TGF-
!1/Smad3+/+ and TGF-!1/Smad3-/- lenses.  Both the wild-type and Smad3-/- lenses show
no expression of !-crystallin in the lens epithelium. The scale bars represents 100 µm (A-
D) and 50 µm (E and F).
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Figure 12. TUNEL staining of apoptotic nuclei (FITC) in TGF-!1/Smad3 lenses
The photographs represent: a TGF-!1/Smad3+/+ (A and C) and a TGF-!1/Smad3-/- (B and
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D) mouse lens.  The yellow arrows indicate the location of subcapsular plaques and the
red arrowheads indicate the location of TUNEL-positive nuclei. The TGF-!1/Smad3+/+
lenses showed a few TUNEL-positive nuclei located in the anterior and posterior regions
of the plaques (A and C).  The TGF-!1/Smad3-/- lenses exhibited more TUNEL-positive
nuclei.  The scale bars represent 100 µm (A and B) and 50 µm (C and D).  The bar graph
represents the percentage of apoptotic nuclei per 150 cells.  *The TGF-!1/Smad3-/- lenses
have significantly more apoptotic nuclei (20.3±5.8%) than the TGF-!1/Smad3+/+
(6.1±1.1%) lenses (unpaired student’s t-test: p % 0.05).
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Figure 13. Optical effects of subcapsular cataract formation in mouse lenses
The bar graph represents the back vertex distance variability (BVD error, mm ± SEM) for
wild-type, TGF-!1/Smad3+/+, TGF-!1/Smad3+/-, and TGF-!1/Smad3-/- mouse lenses.  An
increased in BVD error signifies a decrease in sharpness of light focus through the lens.
+
Statistical analysis (ANOVA: p % 0.05) shows that the TGF-!1/Smad3+/+ and TGF-
!1/Smad3+/- lenses show the greatest BVD errors (0.531±0.071 mm and 0.486 ±0.040
mm respectively) when compared to the wild-type (0.067±0.002 mm) lenses.  *The TGF-
!1/Smad3-/- (0.099±0.005 mm) lenses also show a significantly greater BVD error when
compared to the wild-type lenses.  However, the BVD error of TGF-!1/Smad3-/- lenses is
significantly lower than both TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- lenses.
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Figure 14. TGF-! induced Smad dependent and Smad independent signaling pathways
The above diagram is modified from A. Roberts and R. Derynck, 2001.
67
  Upon ligand
binding, type I and type II receptors are activated and phosphorylation of R-Smads
(Smad2/3) occurs.  Phosphorylated R-Smads form heterotrimeric complexes with Co-
Smad (Smad 4) and translocate to the nucleus.  The Smad complexes interact with other
transcription factors (TF) at DNA sequence-specific binding sites (transcription factor
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binding element (TBE); Smad binding element (SBE)) to regulate gene expression.
Smad7 is an inhibitory Smad that prevents receptor activation of R-Smads.  Smad3
phosphorylation is prevented in Smad3 null mice so TGF-!-induced responses are
presumed to occur through activation of other TGF-!-induced signaling pathways.  TGF-
! also induces activation of mitogen activated protein kinase (MAPK) pathways (JNK,
p38 and ERK1, 2) through upstream mediators: RhoA, Ras, and TAK1.  Additional
pathways involving PI3K have also been shown to mediate EMT.
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2.4 Discussion
TGF-! plays crucial roles during development, homeostasis and pathological
conditions, including ocular fibrotic diseases such as ASC formation and glaucoma.
1, 22,
24, 47
  Typically, TGF-! has inhibitory effects on cells of epithelial origin, while it is
mitogenic for smooth muscle cells and fibroblasts.
24, 48
  In addition, TGF-! can cause an
EMT for various types of epithelial cells in response to injury.  This occurs in the lens
where active TGF-! has been shown to promote the conversion of lens epithelial cells
into myofibroblasts, which form ASC plaques.
1, 16, 20
  Smad3 is an important mediator of
TGF-!-induced fibrosis in the kidney and lung.27, 30, 49  However, the requirement of
Smad3 in the EMT of epithelial cells remains controversial.
50
  In the current study we
have shown that transgenic, expression of TGF-!1 in the lens promotes the formation of
ASCs in the absence of Smad3, demonstrating that Smad3-independent signaling
pathways are activated.
Smad2 is another receptor-mediated Smad that complexes with the Co-Smad
(Smad4).  Thus, one may surmise that Smad2 activation may have compensated for the
loss of Smad3 and contributed to the TGF-! induced EMT in the TGF-!1/Smad3-/- lens
epithelium.  However, although both Smad2 and Smad3 can mediate TGF-! and activin
signaling, they clearly have non-redundant functions.  For example, homozygous mice
with targeted disruptions in the Smad2 gene exhibit embryonic lethality during
gastrulation,
51, 52
 whereas, homozygous Smad3 null mice are viable and survive to
adulthood.
32, 53
  Smad3 and Smad2 have also been shown to have different gene-
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regulatory functions and Smad3, not Smad2, has been linked to fibrotic events.
25, 53, 54
Finally, pSmad2 has been shown to be constitutively expressed in the lens epithelium and
unaffected by TGF-! signaling. 55
While the predominant signaling pathways activated by TGF-! involve the
Smads, additional Smad-independent TGF-! signaling pathways exist that could regulate
the EMT of LECs.  These include the mitogen activated protein kinases (MAPK), such as
c-Jun-N-terminal protein kinases (JNK), extracellular signal-regulated kinases (ERK) and
p38 MAPK.
50, 56-58
  In particular, the p38 MAPK pathway has been shown to play a key
role in TGF-! stimulated EMT and cell migration in many systems including mouse
mammary and human breast epithelial cells.
56, 59
  p38 activation occurs via the TGF-!
activated kinase-1 (TAK1) upstream mediator.
57, 60
  Interestingly, p38 has also been
shown to converge with the Smad pathway in order to produce full effects of EMT in
some cell lines.
61
  This may explain why we observe a less severe corneal and lens
phenotype, including smaller sized plaques, on the Smad3 null background.
Phosphadtidyl-inositol 3-kinase (PI3K) and RhoA are also alternative parallel pathways
shown to be involved in TGF-! mediated EMT of epithelial cells 62-64 and could therefore
be candidate signaling molecules for the EMT of LECs in ASC formation (see Fig. 14).
More recently, it has been shown that other growth factors may be able to mediate EMT
independent of TGF-! signaling pathways (Garcia CM, et al. IOVS 2005;46:ARVO E-
Abstract 4641).
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The EMT of LECs into myofibroblasts has also been shown to occur in a lens
injury model in which the lens capsule is disrupted with a hypodermic needle.
Furthermore, lens injury-induced EMT in the lens was shown to be completely inhibited
on the Smad3-null background.
31
  This is in contrast to our current findings, which show
evidence of EMT and ASC formation in the Smad3 null lens in the presence of the TGF-
!1 transgene.  Reasons for the difference in these findings likely relate to the difference
in the mode of delivery of TGF-! between the two models that could affect the levels and
exposure time of TGF-!. For example, the TGF-!1 transgenic model used in the current
study involves the expression of active TGF-!1 in lens fibre cells, under the control of
the "A-crystallin promoter, which is initiated during early embryogenesis and continues
throughout life of the animal.  In contrast, in the lens injury model, postnatal mice are
utilized and latent TGF-! in lens cells or the aqueous humor is thought to be activated
following a puncture wound to the capsule.
31
  Crystallin promoters are typically strong
promoters and when used to drive active TGF-!1 expression in the lens produce dramatic
lens phenotypes and corneal defects including a thickened, hypercellular corneal stroma
and lack of a stratified corneal epithelium.
1, 24
  In comparison, in the lens injury model
corneal phenotypes have not been reported. This may be due to the fact that the cornea is
fully differentiated in the postnatal mice used for the injury studies. However, it may also
reflect that the levels of TGF-!, and/or length of exposure may be greater in the
transgenic models as compared to the lens injury model. As discussed above, it is
becoming increasingly clear that additional, Smad-independent pathways can regulate
EMT and fibrosis. Thus, it is possible that Smad-independent signaling pathways are
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differentially induced in the two models, and that this results in EMT and subsequent
ASC development in the absence of Smad3 in the transgenic model.
Aberrant ECM deposition is a typical feature of ASC plaques.
1, 7, 45
  We observed
ECM deposition in the subcapsular plaques of all of the TGF-!1 transgenic lenses
examined.  However, the plaques of TGF-!1/Smad3-/- lenses showed only trace amounts
of collagen type IV and substantially less fibronectin staining as compared to the other
TGF-!1 transgenic lenses.  This reduced ECM deposition correlates with the smaller
sized plaques in the TGF-!1/Smad3-/- mice.  There are fewer myofibroblasts to secrete
aberrant ECM.  However, the fact that collagen type IV and fibronectin appeared to be
selectively reduced, whereas collagen I expression did not seem to change dramatically,
suggests that Smad3 controls specific aspects of the ASC phenotype.  Selective changes
in expression of ECM have been previously reported for the Smad3-null mice.  For
example, Smad3 null mice when challenged with streptozotocin to induce diabetes and
glomerular fibrosis show attenuated induction of fibronectin and "3Col4 expression
when compared to their wild-type littermates.
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  A selective induction of fibrotic markers,
such as "SMA, has also been shown to occur following corneal injury in the Smad3-
deficient mice.
66
  Thus, while it is clear that TGF-!-induced EMT in the lens can occur in
the absence of Smad3, other fibrotic gene programs induced during ASC formation may
be Smad3-dependent.
Apoptosis has been shown to be an additional feature of both TGF-!-induced ASC
and PCO.
7, 8, 46
  In this study, we observed apoptotic figures in the plaques of the TGF-!1
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transgenic mice with an increased number in the TGF-!1/Smad3-/- mice as compared to
transgenic wild-type littermates. This may explain why the plaques in the TGF-
!1/Smad3-/- mice remain small relative to their wild-type and heterozygote littermates.
The mechanism by which TGF-! induces apoptosis in the lens is not known. However,
epithelial cells when separated from their basement membrane have been shown to
undergo apoptosis and specifically, type IV collagen, a component of the lens capsule
(basement membrane), has been shown to protect LECs from undergoing Fas-stimulated
apoptosis.
44
  Thus, the deposition of type IV collagen within the plaques of the TGF-!
transgenic mice, which has also been reported in human ASC samples,
43
 may  permit
survival of these cells.  The fact that we observed increased numbers of apoptotic cells in
the TGF-!1/Smad3-/- plaques, in which there was little to no type IV collagen deposition,
further supports a role for type IV collagen in survival of the plaque cells.
We also employed a laser-scanning instrument (ScanTox$) to obtain quantitative
measures of the optical quality of the TGF-! transgenic versus non-transgenic lenses.
The optical measurements obtained were very consistent with the morphological and
molecular data.  For example, all of the TGF-!1 transgenic lenses, which exhibited ASC
plaques, show significantly larger BVD errors (decreased sharpness of focus) relative to
the BVD errors of the wild-type lenses, which are devoid of plaques. Importantly, the
scanning laser instrument was able to discern the effects of size of the subcapsular
plaques amongst the different genotypes on optical quality.  This is likely to be a useful
tool in future transgenic/KO lens studies requiring quantitative measures of lens optical
quality.
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In conclusion, the findings of the current study demonstrate that Smad3 deficiency
does not prevent ASC formation in an in-vivo transgenic TGF-!1 mouse model.  The fact
that the subcapsular plaques were reduced in size in the TGF-!1 transgenic mice on the
Smad3-null background with less type IV collagen and fibronectin deposition as
compared to their wild-type and heterozygote littermates suggests that the Smad3
pathway may selectively regulate aspects of the ASC phenotype.  Uncovering additional
TGF-! signaling mechanisms may provide potential therapeutic targets to help prevent
ASC and closely related ocular fibrotic diseases, such as secondary cataract or PCO.
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3.1 Introduction
The ocular lens is a transparent structure that provides part of the refractive power
needed to focus images on the retina.  The lens is a polarized tissue consisting of a single
layer of cuboidal epithelium in the anterior pole and lens fibre cells occupying the interior
and posterior pole.
1
  The lens grows throughout life by the continuous addition of new
fibre cell layers on top of older fibres, with minimal protein turnover.
2
  The cells that
form the deeper fibres lose their nuclei and become metabolically inert.
3
  A cataract
results in reduced transparency of the lens, which leads to vision loss.  Recently there has
been great interest in human anterior subcapsular cataract (ASC) and posterior capsule
opacification (PCO), which are secondary cataracts formed residual lens epithelial cells
(LECs) after cataract surgery.
4, 5
  Understanding the mechanisms involved in these types
of cataract development can lead to prevention and treatment.
Transforming growth factor beta (TGF-!) is a secreted polypeptide that is
involved in various cellular processes, including cell proliferation, differentiation,
apoptosis, migration and extracellular matrix (ECM) formation.
6-10
  Under physiological
conditions, TGF-! in the lens and ocular media mainly exists in its latent form, whereas
an increase of biologically active TGF-! has been detected in the ocular media from
patients suffering with ASCs.
11, 12
  The three functionally related TGF-! isoforms (TGF-
!1-3) 13 have been shown to induce cataractous changes in in-vitro rat lens cultures and
lens epithelial explants.  However, TGF-!1 is 10 times less potent than TGF-!2 and
TGF-!3.14    Previous in-vivo and in-vitro studies have shown that TGF-!-induced
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epithelial-to-mesenchymal transition (EMT) in transgenic mouse and cultured rat LECs
results in the formation of multilayer plaques and in the transdifferentiation of LECs to
myofibroblasts/fibroblastic or spindle-like cells.  The EMT is also accompanied by
capsular wrinkling, apoptosis, "-smooth muscle actin ("-SMA) expression and an
aberrant deposition of ECM, such as collagen type I and III, fibronectin and tenacin.
5, 6, 15-
18
   It has been established that these TGF-! induced cataractous changes are associated
with ASC and PCO development.
4-6, 18-20
  However, the exact mechanisms involved in
TGF-! induced EMT in LECs are still under investigation.
Fibroblast growth factor (FGF) also plays a role in lens cell survival, proliferation,
migration and differentiation.
21
  Both FGF-1 (acidic) and FGF-2 (basic) are present
continuously in the normal lens environment, with FGF-2 being the more potent
isoform.
22
  Treatment with FGF-2 exacerbates the cataractous effects induced by TGF-!
in cultured rat lenses and lens epithelial explants.
13, 22
  In addition, FGF-2 can reduce the
loss of rat LECs on cultured explants caused by TGF-! induced apoptosis.  It is suggested
that FGF along with TGF-! are involved in PCO development.17, 23
Heat shock proteins (Hsps) are molecular chaperones that were initially identified
as protein expressed after exposure of cells to environmental stress.  However, it has been
proven that Hsps also play a crucial role in proper protein assembly, folding, transport
and degradation under normal conditions.
24, 25
  The heat shock proteins are divided into
families that are classified according to their molecular weight,
25-27
 and each family of




  Previous studies have shown that molecular chaperoning activities
of "-crystallin, Hsp70 and Hsp90 within the lens are critical in maintaining the
supramolecular organization and lens transparency.
29-31
  However, the role of heat shock
proteins in LECs during EMT is unclear.
The most abundant soluble protein in the mammalian lens is "-crystallin, which
plays a prominent role in maintaining the transparency and refractive properties of the
lens.
32, 33
  "-Crystallin (' 800 kDa aggregate) is composed of two homologous subunits,
"A and "B (each with a molecular mass of 20 kDa).34-37  Both "A- and "B- crystallin
demonstrate chaperone-like activity and belong to the small heat shock protein family.
38-
41
 " -Crystallin binds selectively to other unfolded or denatured lens proteins and
suppresses non-specific aggregation.
42
  "-Crystallin also protects the lens from oxidative
stress under physiological conditions.
43
 Furthermore, LECs collected from human
anterior polar type cataracts demonstrate abnormal modification of "-crystallins.41
Hsp70 is another heat shock protein present in the lens epithelium and superficial
cortical fibres in the adult human lens.
30
  Hsp70 is required for correct folding, assembly,
intracellular targeting and degradation of polypeptides and oligomeric proteins.
44
  The
constitutive (Hsc70) and inducible forms of Hsp70 are present in the lens under normal
unstressed conditions.  It is suggested that the normal microenvironment of the lens is
stressful, therefore requiring continuous expression of inducible Hsp70.
30, 45, 46
  Studies
using bovine lenses, mouse LECs and rat lenses show that Hsp70 expression is up-
regulated under heat, oxidative, osmotic, and mechanical stresses.
31, 47
  The chaperone
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activities of Hsp70 require ATP and interaction with other chaperones such as Hsp40 and
Hsp90.
48
   It has been suggested that ATP initiates the interaction of Hsp70 with "-
crystallin and sHsp bound intermediates to convert denatured proteins to their native
state.
30, 42
Hsp90 is one of the most abundant proteins in unstressed eukaryotic cells (1-2%
of all cellular protein).  In mammalian cells there are two functionally similar Hsp90
isoforms, Hsp90"  and Hsp90!.49 Hsp90 is involved in regulating the activity of
intracellular proteins such as steroid hormone receptors and protein kinase.
49, 50
Interestingly, TGF-! has been shown to regulate the expression levels of both Hsp70 and
Hsp90 in cultured CEC (chicken embryo cells).
51
  Hence, heat shock protein may play a
protective role in the LECs during TGF-! induced EMT.
The present study investigates the effects of heat shock treatment and the role of
molecular chaperones in TGF-!2-induced EMT in rat lens epithelial explants.  FGF-2
was also used to exacerbate the effects of TGF-!, as mentioned previously.  The
morphological and molecular changes of the rat lens epithelial explants were examined
and the expressions of "-SMA, F-actin, and E-cadherin were used as indicators of EMT.
The protein expression levels of Hsp70, Hsp90 and "A- and "B-crystallin and apoptotic
cell loss were also analyzed.  The findings of this study show that heat shock treatment
reduces the effects of TGF-!-induced EMT in explanted rat LECs.  Heat shocked TGF-!
epithelial explants demonstrated lower "-SMA expression and greater retention of E-
cadherin expression and organization than non-heat shocked TGF-! explants.  TGF-!-
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induced apoptosis was also reduced in the heat shock rat explants.  Interestingly, this
study also shows that Hsp70, Hsp90 and "A-crystallin protein expressions in the heat
shock treated FGF-2, TGF-!, and TGF-!2/FGF-2 rat LECs are significantly lower than
their respective non-heat shocked groups at four days after initial treatment.
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3.2 Materials and Methods
3.2.1 In-vitro Rat lens epithelial explants
All animal studies were carried out according to the Canadian Council on Animal
Care Guidelines and the Association for Research in Vision and Ophthalmology (ARVO)
Statement for the Use of Animals in Ophthalmic and Vision Research.  Lenses were
dissected from Wistar rats (7-10 day old) after euthanization by cervical dislocation.  The
lens was placed with its anterior side down onto a 35 mm laminin coated culture dish
(BD Biosciences, ON. Canada) containing specialized serum-free medium M199 with
antibiotics.
52
  Lens epithelial explants were prepared by peeling the posterior pole of the
lens capsule and pinning the anterior capsule to the culture dish with the epithelial cells
facing upwards.  The lens fibre mass was removed and discarded.
13, 17
  This provided a
primary rat LEC culture on an intact anterior lens capsule serving as the substratum for
the cells.  The lens epithelial explants were incubated at 37 °C with 4.0% CO2 for 24
hours before any treatment to ensure that they were not damaged during the dissection.
Only explants with a confluent monolayer of LECs were used.  The concentration of
FGF-2 and TGF-!2 used for treatment were 10 ng/ml (FGF-2; PeproTech Inc., NJ. USA)
and 8 ng/ml (TGF-!2; Cedarlane Laboratories Ltd., ON. Canada).  The explants were
divided into eight treatment groups: control (culture medium), FGF-2, TGF-!2 and TGF-
!2/FGF-2 (simultaneous treatment with both TGF-!2 and FGF-2) under normal culture
conditions and heat shocked control (culture medium), FGF-2, TGF-!2, and TGF-
!2/FGF-2.  The culture media was replaced 24 hours after dissection and replaced with
3.5 ml of the appropriate treatment media.  The normal conditioned groups (control,
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FGF-2, TGF-!2, and TGF-!2/FGF-2) were placed back into the incubator. The heat
shocked explants were heat shocked at 45°C for 1 hour and stabilized 37 °C with 4.0%
CO2 for 3 hours prior to treatment with the respective media, as mentioned above.  The
explants were cultured for 4 days in the treatment media and then prepared for
histological, immunohistochemical, Western blot and TUNEL analysis. A total of 440 rat
epithelial explants were used for this study.  All preparations were performed directly
onto the culture dish where the whole epithelial explants remain attached and intact.
3.2.2 Histology and immunohistochemistry staining
A total of 128 rat epithelial explants were used for histological and
immunohistochemical analysis).  Four explants from each of the eight treatment groups
were prepared for each of the four different staining procedures.  The whole-mount of
lens epithelial explants was used for either Hematoxylin and Eosin (H&E), or
immunohistochemistry staining (F-actin, "-SMA and E-cadherin).  The lens epithelial
explants were fixed in 4% paraformaldahyde for 30 minutes, then permeablized with
0.1% TritonX-100 in 1X phosphate buffered saline solution (PBS) for 15 minutes at room
temperature.  H&E staining procedures were performed on the epithelial explants and
after staining, the sides of the culture dish were removed and a round glass coverslip was
applied.  The epithelial explants were visualized with a Leica microscope and images
were captured using a high-resolution camera and associated software (OpenLab;
Quorum Technologies Inc., CA. USA).  Images were reproduced for publication using
Adobe Photoshop 9.0.1 (Adobe Systems Inc., CA. USA).
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For "-SMA and E-cadherin immunoflourescence localization, the whole-mount
lens epithelial explants were incubated with 5% normal goat serum for 30 minutes at
room temperature.  The explants were then incubated overnight at 4 °C, either with
mouse anti-"-SMA monoclonal antibody (1:400; Sigma-Aldrich Inc., MO. USA) or
mouse anti-E-cadherin antibody (1:100; BD Biosciences, ON. Canada).  An Alexa Fluor
488 conjugated goat anti-mouse secondary antibody (1:100; Invitrogen Inc., ON. Canada)
was used for detection of the bound primary antibodies.  All whole-mount explants were
mounted in Vectashield mounting medium with 4’,6-Diaminodino-2-Phenylindol (DAPI,
Vector Laboratories Inc., CA. USA) to visualize the nuclei.  A round glass coverslip was
applied and the sides of the culture dish were removed.  A Zeiss scanning laser confocal
microscope (LSM 510 META) equipped with an Argon-Krypton laser was use to
examine the immunoreactivity of the epithelial explants.  Cross-sections of the explants
were visualized with confocal z-stack using an optical slice thickness of 0.3 µm, the
images were captured using the Zeiss LSM software.  Adobe Photoshop 9.0.1 was also
used to reproduce images for publication.
For F-actin localization, whole-mount lens epithelial explants were incubated with
5% normal goat serum for 30 minutes at room temperature.  The explants were then
incubated with Alexa 546 phalloidin (1:50; Invitrogen Inc., ON. Canada) for 30 minutes
at room temperature.  The epithelial explants were mounted in Vectashield mounting
medium with DAPI to visualize the nuclei.  A round glass coverslip was applied and the
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sides of the culture dish were removed.  Laser scanning confocal microscopy was
performed as described above.
3.2.3 TUNEL assay
TUNEL (terminal deoxynucleotidyl transferase mediated dUTP nick end labeling)
labeling was used to examine cell death in three lens epithelial explants of each treatment
group.  A total of 24 explants were used. The whole-mount epithelial explants were fixed
and permeablized as described above.  The ApopTag plus flourescein in-situ apoptosis
detection kit (Chemicon International Inc., CA. USA) was used to detect apoptotic nuclei
and the TUNEL procedure was carried out in accordance with the manufacturer’s
instructions.  A positive control was prepared by treating a sample with DNaseI prior to
TUNEL staining.  All sections were mounted in Vectashield mounting medium with
DAPI and photographed using the laser scanning confocal microscope.  For quantitative
analysis, the percentage of TUNEL-positive cells among 150 lens epithelial cells in three
fields per section was determined at 250-fold magnification.
3.2.4 Western blot analysis
Thirty-six epithelial explants from each of the eight treatment groups were
collected and pooled (in groups of four explants) for Western blot analysis of "-SMA, E-
cadherin, "A-crystallin, "B-crystallin, Hsp70 and Hsp90 protein expression (total
n=288). The lens epithelial explants were homogenized in Triton-X100 lysis buffer
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containing protease inhibitor cocktail (Roche Applied Science, IN. USA).  Total protein
concentration was determined by the Bradford protein assay.
53
  Equal amounts of total
protein from each group of explants were electrophoresed on 10% SDS polyacrylamide
gel.  In addition, a heat shocked HeLa cell lysate (Stressgen Bioreagents, MI. USA) was
loaded and used as a positive control for heat shocked proteins.  The proteins were
electro-transferred onto a nitrocellulose membrane (Pall Corporation, NY. USA).
Membranes were blocked with 5% skimmed milk powder in Tris-buffered saline (50mM
Tris base, NaCl pH 8.5) + 0.1% Tween-20 and then incubated overnight at 4°C with
either a mouse anti-"-SMA monoclonal antibody (1:1000), rabbit anti-"A-crystallin
polyclonal antibody (1:1000) or rabbit anti-"B-crystallin polyclonal antibody (1:1000).
Following this incubation, membranes were probed with the appropriate HRP-conjugated
anti-rabbit or anti-mouse secondary antibodies (1:5000; Amersham Biosciences, NJ.
USA) and ECL detection reagents (Amersham Biosciences, NJ. USA).  The Western
blots were visualized by x-ray film exposure.  The membranes were stripped and
reprobed with either a mouse anti-E-cadherin antibody (1:2500), rabbit anti-Hsp70
polyclonal antibody (1:2000), or rabbit anti-Hsp90 polyclonal antibody (1:2000) followed
by the appropriate secondary detection as mentioned above. The "A-crystallin, "B-
crystallin, Hsp70, and Hsp90 antibodies were purchased from Stressgen Bioreagents (MI.
USA). The membranes were stripped a second time and reprobed with a mouse anti-!-
actin antibody (1:1000; Cedarlane Laboratories Ltd., ON Canada) as a loading control.
The secondary detection for !-actin followed the same procedures as mentioned above.
The bands were quantitated by densitometry and normalized with !-actin using ImageJ
software (software available at http://rsb.info.nih.gov/ij/download.html; developed by
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Wayne Rasband, National Institutes of Health, Bethesda, MD).  Protein expression is
expressed as a percentage of normal control ± standard error of the mean (%±SEM).
3.2.5 Statistical analysis
The analysis of variance (ANOVA; SPSS$ 11.0 statistical software) was used to
assess the treatment effects on protein expression and apoptotic cell death of rat lens
epithelial explants.  The Tukey’s post-hoc test was use to determine the significance




3.3.1 Histological and immunohistochemical analysis of rat lens epithelial explants
Histological examination of cultured lens epithelial explants from 7-10 day old
rats treated with TGF-!2 and TGF-!2/FGF-2 under both normal and heat shocked
conditions revealed distinct evidence of EMT including extensive multi-layering of cells
forming plaques on the anterior lens capsule (Fig. 1 and 2 E-H).  In contrast to the
plaques formed on the TGF-!2/FGF-2 treated explants (Fig. 2 G, H), which are typically
large and diffuse, the plaques in the TGF-!2 explants (Fig. 2 E, F) were substantially
smaller. Capsular wrinkling as well as fibroblastic and spindle shaped cell formation also
occurred in the TGF-! treated explants (not shown).  The control and FGF-2 epithelial
explants demonstrated a confluent monolayer of LECs with a cobblestone pattern and did
not form multilayer plaques (Fig. 2 A-D).  However the FGF-2 treated explants exhibited
a more rounded cellular appearance and greater cell density per area than the controls.
The cellular morphology of heat shocked groups (Fig. 2 B, D, F, H) did not differ
significantly from the normal condition groups for each of the four conditions (Fig. 2 A,
C, E, G).  Heat shock treatment did not inhibit TGF-! induced plaque formation.  But the
plaques formed on the heat shocked TGF-!2/FGF-2 treated explants were less severe and
spanned a smaller area of the explants when compared to the non-heat shocked TGF-
!2/FGF-2 plaques.
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The expression of F-actin and "-SMA were next examined since these are
commonly used as markers for TGF-!-induced EMT (Figs. 3 and 4).54  The control
explants (Fig 3 A, B) demonstrate normal polygonal arrays of F-actin stress fibres
underlying the apical location of the LEC membranes.
55
  Interestingly, treatment with
FGF-2 significantly reduced the F-actin immunoreactivity in the LEC cytoplasm and the
F-actin expression was mainly confined to the cell borders.  The TGF-!2 (Fig. 3 E, F)
treated explants demonstrated a slight increase in F-actin immunoreactivity and stress
fibre extension when compared to the controls (Fig. 3 A, B).  Whereas the simultaneous
treatment of epithelial explants with TGF-!2 and FGF-2 (Fig. 3 G, H) induced the
formation of substantially longer peripheral extension of F-actin filaments in the plaques.
There was no significant difference in F-actin immunoreactivity between the normal
cultured explants (A, C, E and G) and heat shocked explants (B, D, F and H).  The
increase in stress fibre formation and reorganization in the lens epithelial explants
demonstrates the occurrence of TGF-!-induced EMT in the LECs.
Expression of "-SMA was also observed in the multilayer plaques of the TGF-!2
and TGF-!2/FGF-2 lens epithelial explants, whereas no "-SMA expression was detected
in the FGF-2 treated explants (Fig. 4).  The control explants showed diffuse staining of "-
SMA in the cytoplasm of some LECs (Fig. 4. A, B). The TGF-!2 treated explants (Fig 4.
E, F) demonstrated greater "-SMA immunoreactivity and more filamentous expression of
"-SMA in the apical portion of the cells.  The simultaneous treatment of epithelial
explants with TGF-!2 and FGF-2 (Fig. 4 G, H) induced the greatest " - S M A
immunoreactivity, with the formation of substantially longer and extended "-SMA
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filaments in the plaques.   Interestingly, the heat shocked epithelial explants (Fig. 4 B, F
and H) show significantly lower "-SMA immunoreactivity than the same treatment
groups under normal culture conditions (Fig. 4 A, E and G respectively).  Fewer cells
from the heat shocked control explants show "-SMA staining when compared to the non-
heat shocked control explants.  The heat shocked TGF-!2 and TGF-!2/FGF-2 explants
show less filamentous "-SMA staining than the non-heat shocked TGF-!2 and TGF-
!2/FGF-2 explants.  The results from Western blot analysis of "-SMA (42 kDa)
expression in lens epithelial explants (Fig. 5, Table 1) confirmed the immunostaining
results.  Statistical analysis (ANOVA: p % 0.05) shows that there is a significant treatment
effect.  The heat shocked control (lane 2, 55.7±5.6%) epithelial explants show
significantly lower levels "-SMA protein expression compared to the normal control
(lane 1, 100%) epithelial explants, while the FGF-2 treated explants (normal (lane 3,
6.7±3.5%) and heat shocked (lane 4, 1.4±0.7%)) show negligible amounts of "-SMA.
The treatment with TGF-!2 (normal (lane 5, 255.2±3.3%), heat shocked (lane 6,
170.0±.8.4%)) and TGF-!2/FGF-2 (normal (lane 7, 363.0±4.8%), heat shocked (lane 8,
293.4±.2.3%)) demonstrated a significant increase in "-SMA protein expression, with the
greatest increase of "-SMA expression in the TGF-!2/FGF-2 explants.  In addition, the
"-SMA expression of heat shock treated TGF-!2 and TGF-!2/FGF-2 explants are
significantly lower than the same treatment groups under normal cultured conditions.  !-
actin (42 kDa) protein, used as a loading control, showed equal levels of expression in all
samples examined.  Therefore in contrast to F-actin expression, "-SMA expression is
reduced in the heat shocked TGF-! groups.
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E-cadherin is an epithelial marker which is localized at the adherence junctions
and the disassembly of E-cadherin is associated with TGF-!-induced EMT.56  Both the
control (Fig. 6 A, B) and FGF-2 (Fig. 6 C, D) treated explants show normal E-cadherin
expression at the cell-cell junction locations.  The TGF-!2 (Fig. 6 E, F) treated explants
demonstrated lower E-cadherin immunoreactivity and a loss of E-cadherin in some LECs
when compared to the controls.  The simultaneous treatment of epithelial explants with
TGF-!2 and FGF-2 (Fig. 6 G, H) induced considerable loss of E-cadherin organization
and diffused staining.  Heat shock treatment did not affect the E-cadherin expression
levels in both the control and FGF-2 epithelial explants.  However, heat shock TGF-!2
and TGF-!2/FGF-2 (Fig. 6 F, H) demonstrated higher immunoreactivity and organization
of E-cadherin than normal TGF-!2 and TGF-!2/FGF-2 (Fig. 6 E, G) explants
respectively.  Results from Western blot analysis of E-cadherin (120 kDa) expression in
lens epithelial explants (Fig. 7, Table 1) confirmed the immunostaining results.
Statistical analysis (ANOVA: p % 0.05) showed that there is a significant treatment effect.
Both the normal control (lane 1, 100%) and heat shocked control (lane 2, 100.3±1.8%)
explants expressed similar levels of E-cadherin protein.  FGF-2 treatment (normal (lane
3, 119.5±8.5%) and heat shocked (lane 4, 126.6±5.9%)) induced significant increase of
E-cadherin expression when compared to the normal control epithelial explants.  Both
treatment with TGF-!2 (normal (lane 5, 70.0±1.8%), heat shocked (lane 6, 86.7±.3.1%))
and TGF-!2/FGF-2 (normal (lane 7, 45.6±2.6%), heat shocked (lane 8, 72.6±.3.4%))
demonstrated a significant decrease in E-cadherin protein expression, with the greatest
loss of E-cadherin expression in the normal TGF-!2/FGF-2 explants.  However, the E-
cadherin expression of heat shocked TGF-!2 and TGF-!2/FGF-2 explants were
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significantly higher than the same treatment groups under normal culture conditions.  !-
actin protein expression showed that equal levels of total protein from each sample were
loaded.  The decrease in E-cadherin expression coincided with increased expression of F-
actin and "-SMA in TGF-! treated explants.  Therefore these results show that TGF-!
induced EMT in the rat LECs.  Although heat shock treatment did not inhibit TGF-!-
induced multilayer plaque formation, it reduced the severity of EMT, as shown in the "-
SMA and E-cadherin results.
3.3.2 Apoptotic cell death in rat lens epithelial explants
Since TGF-! induced multilayer plaque formation in lens epithelial explants, and
apoptosis has been reported to occur in TGF-!-induced anterior subcapsular cataracts
(ASC) 
57, 58
, we utilized TUNEL labeling to examine the level of apoptosis in the
different experimental groups (Fig. 8).  The photographs in figure 8 represent the TUNEL
staining in a normal control (A) and TGF-!2/FGF-2 (B) explants.  Both TGF-!2/FGF-2
and TGF-!2 (latter not shown) showed an increase of TUNEL-positive nuclei in the
plaques when compared to the control, whereas the FGF-2 lens epithelial explants show
negligible amounts of TUNEL-positive nuclei (photograph not shown).  Statistical
analysis (ANOVA: p % 0.05) shows that there is a significant treatment effect.  The heat
shocked control (2.3±0.6%) epithelial explants demonstrated less apoptotic cell death
than the control (4.3±0.5%) explants under normal culture conditions, but the decrease is
not significant.  FGF-2 treatment (normal (1.9±0.6%) and heat shock (0.8±0.2%))
induced significant decreases in apoptotic cell death relative to the normal control
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epithelial explants.  The normal TGF-!2 (7.5±0.8%) and TGF-!2/FGF-2 (normal
(9.6±0.6%), heat shocked (6.8±.0.5%)) explants demonstrated a significant increase in
cell death.  The increase of cell death in the heat shocked TGF-!2 (4.6±0.7%) explants is
not significantly different from normal control explants.  In addition, the heat shocked
TGF-!2 and TGF-!2/FGF-2 explants demonstrated significantly lower apoptotic cell
death than the same treatment groups under normal cultured conditions.  Thus, TGF-!-
induced apoptosis was reduced by heat shock treatment in rat lens epithelial explants.
3.3.3 Effect of the TGF-!2 on heat shock protein expressions in rat lens epithelial
explants
As mentioned in the introduction, "A- and "B- crystallin demonstrate chaperone-
like activity and belong to the small heat shock protein family.  The decrease of "-
crystallin chaperone activity has been attributed to the loss of lens transparency and
cataract formation.
38-42
  Thus, the expression levels of "A- and "B-crystallins were also
investigated and the results are described in figures 9 and 10 (also see Table 1).  The !-
actin protein expression in both Western blot analyses showed that equal levels of total
protein from each sample was loaded.  The results of figure 9 show that heat shock
treatment of control (lane 2, 48.9±1.3%), TGF-!2 (lane 6, 46.8±5.0%) and TGF-!2/FGF-
2 (lane 8, 35.2±4.5%) epithelial explants significantly (ANOVA: p % 0.05) lower the
levels of "A-crystallin (20 kDa) protein expression when compared to the normal control
(lane 1, 100%) explants. There is also a decrease of "A-crystallin expression in normal
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TGF-!2 (lane 5, 87.1±2.3%) and TGF-!2/FGF-2 (lane 7, 94.1±2.3%), but the decrease is
not significant.  In addition, the heat shock treated TGF-!2 and TGF-!2/FGF-2 explants
demonstrated significantly lower "A-crystallin expression than the same treatment
groups under normal culture conditions.  In contrast, FGF-2 (normal (lane 3,
124.0±1.2%), heat shock (lane 4, 114.8± .4.3%)) treated explants demonstrate a
significant increase of "A-crystallin protein expression when compared to normal control
explants.
Unlike "A-crystallin, Western blot results of "B-crystallin protein expression of
the different treatment groups did not show a significant treatment effect (ANOVA: p (
0.05).  Results shown in figure 10 show that the control (lane 1, 100%), FGF-2 (lane 3,
112.0±2.3%), TGF-!2 (lane 5, 101.6±4.6%) and TGF-!2/FGF-2 (lane 7, 106.5±1.6%)
explants under normal culture conditions are similar to the heat shocked explants: control
(lane 2, 109.0±4.0%), FGF-2 (lane 4, 111.5±2.3%), TGF-!2 (lane 6, 99.5±3.5%) and
TGF-!2/FGF-2  (lane 8, 101.3±2.7%).
Western blot analysis of Hsp70 (70 kDa, Fig. 11, Table 1) shows that there is a
significant treatment effect (ANOVA: p % 0.05) between the different groups.  A heat
shocked HeLa cell lysate was used as a positive control.  The !-actin protein expression
also showed that equal levels of total protein were loaded for each sample.  Heat shock
treatment did not affect Hsp70 levels in the control epithelial explants (normal lane1,
100% and heat shocked lane 2, 99.6±2.7%). While Hsp70 expression significantly
decreased in the normal FGF-2 (lane 3, 73.5±4.7%) and heat shocked FGF-2 (lane 4,
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54.6±3.7%).  The heat shocked TGF-!2 (lane 6, 83.5±1.6%) treated explants also show
significant decrease in Hsp70 expression when compared to the control explants.  In
contrast, the normal TGF-!2 (lane 5, 118.0±3.3%) and TGF-!2/FGF-2 (normal (lane 7,
211.6±4.5%), heat shocked (lane 8, 124.7±.4.0%)) explants show significant increase of
Hsp70 protein expression, with the greatest increase in the TGF-!2/FGF-2 explants.  In
addition, the Hsp70 expression of heat shocked FGF-2, TGF-!2 and TGF-!2/FGF-2
explants are significantly lower than the same respective treatment groups under normal
culture conditions.
The results from the Hsp90 protein analysis (90 kDa, Fig. 12, Table 1) also show
significant treatment effect (ANOVA: p % 0.05).  As mentioned above, the HeLa cell
lysate was used as a positive control.  The !-actin protein expression also showed that
equal levels of total protein were loaded from each sample.  Heat shocked treatment
significantly decreased the Hsp90 expression levels in the control (lane 2, 55.6±1.1%)
and TGF-!2 (lane 6, 73.6±6.0%) epithelial explants when compared to normal control
(lane 1, 100%) epithelial explants.  Although there is also a decrease of Hsp90 expression
in the normal TGF-!2 (lane 5, 93.9±2.5%), it is not significant.  The FGF-2 (normal (lane
3, 172.6±2.5%), heat shocked (lane 4, 129.0±.3.3%)) and TGF-!2/FGF-2 (normal (lane
7, 187.0.±5.3%), heat shocked (lane 8, 157.0±5.3%)) explants show significant increase
of Hsp90 protein expression, with the greatest increase in the TGF-!2/FGF-2 explants.
Heat shock treatment also significantly decreased the Hsp90 expression levels of FGF-2,
TGF-!2 and TGF-!2/FGF-2 explants when compared to the same treatment groups under
normal culture conditions.   Interestingly, the heat shocked TGF-! (TGF-!2 and TGF-
106
!2/FGF-2) explants demonstrated lower levels of "A-crystallin, Hsp70 and Hsp90 than
the TGF-! explants under normal culture conditions.  This may be an indication that heat
shock treatment reduced TGF-!-induced stress conditions in the epithelial explants.
Thus, there is less up-regulation of molecular chaperone activities in the heat shocked
TGF-! explants when compared to the TGF-! explants under normal conditions.
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Figure 1. Cultured rat lens epithelial explants
The phase contrast photographs represent a control (A) and a TGF-!2/FGF-2 treated (B)
lens epithelial explant.  Panel C shows a confocal z-stack section (a y-axis projection) of
a TGF-!2/FGF-2 treated lens epithelial explant.  The control rat explant demonstrates a
regular monolayer of lens epithelial cells, while the TGF-!2/FGF-2 (B and C) treated
explants formed spindle shaped cells and mutilayer plaques (arrows).
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Figure 2. Histological analysis of rat lens epithelial explants
Control (A and B), FGF-2 (C and D), TGF-!2 (E and F) and TGF-!2/FGF-2 (G and H)
lens epithelial explants under normal conditions (A, C, E and G) and after heat shocked
(B, D, F and H) treatment are shown.   N=4 for each treatment group.  Control epithelial
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cells (A and B) show normal morphology.  FGF-2 treated explants (C and D) have
rounder cells and also show greater cell density then the control explants.  Treatment with
TGF-!2 (E-H) induced formation of multilayer plaques (arrows).  The simultaneous
treatment of epithelial explants with TGF-!2 and FGF-2 (G and H) induced the formation
of considerably larger and more diffused plaques than TGF-!2 (E and F) alone.  Both the
heat shocked and normal cultured explants show similar phenotype for each of the four
conditions. However, the plaques formed on the heat shocked TGF-!2/FGF-2 explants
are less severe and less expansive than the non-heat shocked TGF-!2/FGF-2 plaques.
The scale bar represents 100 µm.
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Figure 3. Immunohistochemical analysis of F-actin expression
F-actin was stained with Alexa 546 phalloidin and analyzed by confocal microscopy.
Control (A and B), FGF-2 (C and D), TGF-!2 (E and F) and TGF-!2/FGF-2 (G and H)
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lens epithelial explants under normal conditions (A, C, E and G) and after heat shock (B,
D, F and H) treatment are shown. N=4 for each treatment group.  Control epithelial cells
(A and B) show normal expression of F-actin, while FGF-2 treated explants (C and D)
show a significant decrease of F-actin immunoreactivity in the cytoplasm.  FGF-2 treated
explants show F-actin staining mainly around the cell borders.  The TGF-!2 (E and F)
treated explants demonstrate a slight increase (arrows) of F-actin immunoreactivity and
stress fibre extension when compared to the controls (A and B).  Whereas the
simultaneous treatment of epithelial explants with TGF-!2 and FGF-2 (G and H) induced
the formation of substantially longer peripheral extensions of F-actin filaments in the
plaques (arrows).   There is no significant difference of F-actin immunoreactivity
between the normal cultured explants (A, C, E and G) and heat shocked explants (B, D, F
and H) for each of the four conditions.  The scale bar represents 50 µm.
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Figure 4.  Immunohistochemical analysis of "-Smooth muscle actin expression
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The analysis of "-SMA immunoreactivity (Alexa fluor 488) using confocal microscopy.
Control (A and B), FGF-2 (C and D), TGF-!2 (E and F) and TGF-!2/FGF-2 (G and H)
lens epithelial explants under normal conditions (A, C, E and G) and after heat shock (B,
D, F and H) treatment are shown. N=4 for each treatment group.  Some control epithelial
cells (A and B) show diffuse staining of "-SMA in the cytoplasm in a few cells, while
FGF-2 treated explants (C and D) show negligible "-SMA immunoreactivity.  The TGF-
!2 (E and F (arrows)) treated explants demonstrate greater "-SMA immunoreactivity and
more filamentous expression of "-SMA in the cell cytoplasm when compare to the
controls (A and B).  The simultaneous treatment of epithelial explants with TGF-!2 and
FGF-2 (G and H (arrows)) induced the greatest "-SMA immunoreactivity with the
formation of substantially longer and extended "-SMA filaments in the plaques.   The
heat shocked epithelial explants (B, F and H) show considerably lower " -SMA
immunoreactivity than the same treatment groups under normal cultured conditions (A, E
and G respectively).  The scale bar represents 50 µm.
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Figure 5. "-Smooth muscle actin protein expression
A total of twelve lens epithelial explants from each of the eight treatment groups were
used for Western blot analysis of "-SMA (42 kDa) protein expression.  Control (lanes 1
and 2), FGF-2 (lanes 3 and 4), TGF-!2 (lanes 5 and 6) and TGF-!2/FGF-2 (lanes 7 and
8) lens epithelial explants under normal conditions (lanes 1, 3, 5 and 7) and after heat
shock (lanes 2, 4, 6 and 8) treatment are shown.  !-actin (42 kDa) protein expression
serves as an internal control and shows that equal amounts of total protein were loaded in
all lanes.
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The bar graph represents the "-SMA protein expression (percent of normal control, % ±
SEM) for control, FGF-2, TGF-!2 and TGF-!2/FGF-2 treated lens epithelial explant
extracts from normal culture and heat shocked conditions.  Statistical analysis (ANOVA:
p % 0.05) shows that there is a significant treatment effect. 
+
The heat shocked control
(55.7±5.6%) and FGF-2 (normal (6.7±3.5%) and heat shocked (1.4±0.7%)) epithelial
explants show significantly lower levels of "-SMA protein expression compared to the
normal control (100%) epithelial explants.  
•
The treatment with TGF-!2 (normal
(255.2±3.3%), heat shocked (170.0±.8.4%)) and TGF-!2/FGF-2 (normal (363.0±4.8%),
heat shocked (293.4±.2.3%)) demonstrate a significant increase of "-SMA protein
expression, with the greatest increase of "-SMA expression in the TGF-!2/FGF-2
explants.  *In addition, the "-SMA expression of heat shocked TGF-!2 and TGF-
!2/FGF-2 explants are significantly lower than the same treatment groups under normal
cultured conditions.
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Figure 6. Immunohistochemical analysis of E-cadherin expression
The analysis of E-cadherin immunoreactivity (Alexa fluor 488) using confocal
microscopy. Control (A and B), FGF-2 (C and D), TGF-!2 (E and F) and TGF-!2/FGF-2
(G and H) lens epithelial explants under normal conditions (A, C, E and G) and after heat
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shock (B, D, F and H) treatment are shown. N=4 for each treatment group.  Both the
control (A and B) and FGF-2 (C and D) treated explants show normal E-cadherin
expression.  The TGF-!2 (E and F (arrows)) treated explants demonstrate lower E-
cadherin immunoreactivity when compare to the controls.  The simultaneous treatment of
epithelial explants with TGF-!2 and FGF-2 (G and H) induced substantial loss of E-
cadherin organization and diffused staining (arrows).  Heat shock treatment did not affect
the E-cadherin expression levels in both the control and FGF-2 epithelial explants.
However, the heat shock TGF-!2 and TGF-!2/FGF-2 (F and H) demonstrate higher
immunoreactivity and organization of E-cadherin than the normal TGF-!2 and TGF-
!2/FGF-2 (E and G) explants, respectively.  The scale bar represents 50 µm.
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Figure 7. E-cadherin protein expression
A total of twelve lens epithelial explants from each of the eight treatment groups were
used for Western blot analysis of E-cadherin protein (120 kDa) expression.  Control
(lanes 1 and 2), FGF-2 (lanes 3 and 4), TGF-!2 (lanes 5 and 6) and TGF-!2/FGF-2 (lanes
7 and 8) lens epithelial explants under normal conditions (lanes 1, 3, 5 and 7) and after
heat shocked (lanes 2, 4, 6 and 8) treatment are shown.  !-actin (42 kDa) protein
expression serves as an internal control and shows that equal amounts of total protein
were loaded in all lanes.
The bar graph represents the E-cadherin protein expression (percent of normal control, %
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± SEM) for control, FGF-2, TGF-!2 and TGF-!2/FGF-2 treated lens epithelial explant
extracts from normal culture and heat shock conditions.  Statistical analysis (ANOVA: p
% 0.05) shows that there is a significant treatment effect.  Both the normal control (100%)
and heat shocked control (100.3±1.8%) explants express similar levels of E-cadherin
protein.  
•
FGF-2 treatment (normal (119.5±8.5%) and heat shocked (126.6±5.9%))
induced significant increase of E-cadherin expression when compared to the normal
control epithelial explants. 
+
Both treatment with TGF-!2 (normal (70.0±1.8%), heat
shocked (86.7±.3.1%)) and TGF-!2/FGF-2 (normal (45.6±2.6%), heat shocked
(72.6±.3.4%)) demonstrate a significant decrease of E-cadherin protein expression, with
the greatest decrease of E-cadherin expression in the normal TGF-!2/FGF-2 explants.
*However, the E-cadherin expression of heat shocked TGF-!2 and TGF-!2/FGF-2
explants are significantly higher than the same treatment groups under normal cultured
conditions.
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Figure 8. Apoptotic cell death in the rat lens epithelial explants
The photographs represent: a control
 
(A) and a TGF-!2/FGF-2 (B) treated rat epithelial
explant. The scale bar represents 100 µm.  The TUNEL-positive nuclei are present as
green nuclei. The control explant exhibited only a few TUNEL-positive nuclei.  While
the TGF-!1/FGF-2 treated epithelial explants show a greater number of TUNEL-positive
nuclei located in the plaques (yellow arrows).
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The bar graph represents the percentage of apoptotic nuclei per 150 cells for control,
FGF-2, TGF-!2 and TGF-!2/FGF-2 treated lens epithelial explant extracts from normal
culture and heat shock conditions.  A total of three lens epithelial explants from each of
the eight treatment groups were used for TUNEL analysis.  Statistical analysis (ANOVA:
p % 0.05) shows that there is a significant treatment effect.  The heat shocked control
(2.3±0.6%) epithelial explants demonstrate less apoptotic cell death than the control
(4.3±0.5%) explants under normal cultured conditions, but the decrease is not significant.
+
FGF-2 treatment (normal (1.9±0.6%) and heat shocked (0.8±0.2%)) induced significant
decrease of apoptotic cell death relative to the normal control epithelial explants.  
•
The
normal TGF-!2 (7.5±0.8%) and TGF-!2/FGF-2 (normal (9.6±0.6%), heat shocked
(6.8±.0.5%)) explants demonstrate a significant increase of cell death.  The increase of
cell death in the heat shocked TGF-!2 (4.6±0.7%) explants is not significantly different
from normal control explants.  *In addition, the heat shocked TGF-!2 and TGF-!2/FGF-
2 explants demonstrate significantly lower apoptotic cell death than the same treatment
groups under normal cultured conditions.
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Figure 9. "A-crystallin protein expression
A total of twelve lens epithelial explants from each of the eight treatment groups were
used for Western blot analysis of "A-crystallin (20 kDa) protein expression.  Control
(lanes 1 and 2), FGF-2 (lanes 3 and 4), TGF-!2 (lanes 5 and 6) and TGF-!2/FGF-2 (lanes
7 and 8) lens epithelial explants under normal conditions (lanes 1, 3, 5 and 7) and after
heat shocked (lanes 2, 4, 6 and 8) treatment are shown.  !-actin (42 kDa) protein
expression serves as an internal control and show that equal amounts of total protein were
loaded in all lanes.
The bar graph represents the "A-crystallin protein expression (percent of normal control,
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% ± SEM) for control, FGF-2, TGF-!2 and TGF-!2/FGF-2 treated lens epithelial explant
extracts from normal culture and heat shock conditions.  Statistical analysis (ANOVA: p
% 0.05) shows that there is a significant treatment effect. +The heat shock treatment of
control (48.9±1.3%), TGF-!2 (46.8±5.0%) and TGF-!2/FGF-2 (35.2±4.5%) epithelial
explants significantly reduced the levels of "A-crystallin protein expression compared to
the normal control (100%) epithelial explants. The decrease of "A-crystallin expression
in normal TGF-!2 (87.1±2.3%) and TGF-!2/FGF-2 (94.1±2.3%) explants are not
significant. *In addition, the heat shock treated TGF-!2 and TGF-!2/FGF-2 explants
demonstrate significantly lower "A-crystallin expression than the same treatment groups
under normal cultured conditions.  •The FGF-2 (normal (124.0±1.2%), heat shock
(114.8±.4.3%)) treated explants demonstrate a significant increase of "A-crystallin
protein expression when compared to normal control explants.
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Figure 10. "B-crystallin protein expression
A total of twelve lens epithelial explants from each of the eight treatment groups were
used for Western blot analysis of "B-crystallin (22 kDa) protein expression.  Control
(lanes 1 and 2), FGF-2 (lanes 3 and 4), TGF-!2 (lanes 5 and 6) and TGF-!2/FGF-2 (lanes
7 and 8) lens epithelial explants under normal conditions (lanes 1, 3, 5 and 7) and after
heat shocked (lanes 2, 4, 6 and 8) treatment are shown.  !-actin (42 kDa) protein
expression serves as an internal control and shows that equal amounts of total protein
were loaded in all lanes.
The bar graph represents the "B-crystallin protein expression (percent of normal control,
% ± SEM) for control, FGF-2, TGF-!2 and TGF-!2/FGF-2 treated lens epithelial explant
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extracts from normal culture and heat shocked conditions.  Statistical analysis (ANOVA:
p % 0.05) shows that there is no significant treatment effect.  The "B-crystallin protein
expression of control (100%), FGF-2 (112.0±2.3%), TGF-!2 (101.6±4.6%) and TGF-
!2/FGF-2 (106.5±1.6%) explants under normal culture conditions are similar to the heat
shocked explants: control (109.0±4.0%), FGF-2 (111.5±2.3%), TGF-!2 (99.5±3.5%) and
TGF-!2/FGF-2  (101.3±2.7%).
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Figure 11. Hsp70 protein expression
A total of twelve lens epithelial explants from each of the eight treatment groups were
used for Western blot analysis of Hsp70 (70 kDa) protein expression.  HeLa cell lysate
(positive control), control (lanes 1 and 2), FGF-2 (lanes 3 and 4), TGF-!2 (lanes 5 and 6)
and TGF-!2/FGF-2 (lanes 7 and 8) lens epithelial explants under normal conditions
(lanes 1, 3, 5 and 7) and after heat shock (lanes 2, 4, 6 and 8) treatment are shown.  !-
actin (42 kDa) protein expression serves as an internal control and shows that equal
amounts of total protein were loaded in all lanes.
The bar graph represents the Hsp70 protein expression (percent of normal control, % ±
SEM) for control, FGF-2, TGF-!2 and TGF-!2/FGF-2 treated lens epithelial explant
extracts from normal culture and heat shocked conditions.  Statistical analysis (ANOVA:
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p % 0.05) shows that there is a significant treatment effect.  Both the normal control
(100%) and heat shocked control (99.6±2.7%) explants express similar levels of Hsp70
protein.  
+
FGF-2 (normal (73.5±4.7%) and heat shocked (54.6±3.7%)) and heat shocked
TGF-!2 (83.5±1.6%) treated explants demonstrate significant lower levels of Hsp70
expression when compared to normal control epithelial explants.  
•
The normal TGF-!2
(118.0±3.3%) and TGF-!2/FGF-2 (normal (211.6±4.5%), heat shocked (124.7±.4.0%))
explants show significant increases in Hsp70 protein expression, with the greatest
increase in the TGF-!2/FGF-2 explants.  *In addition, the Hsp70 expression of heat
shocked FGF-2, TGF-!2 and TGF-!2/FGF-2 explants are significantly lower than the
same treatment groups under normal cultured conditions.
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Figure 12. Hsp90 protein expression
A total of twelve lens epithelial explants from each of the eight treatment groups were
used for Western blot analysis of Hsp90 (90 kDa) protein expression.  HeLa cell lysate
(positive control), control (lanes 1 and 2), FGF-2 (lanes 3 and 4), TGF-!2 (lanes 5 and 6)
and TGF-!2/FGF-2 (lanes 7 and 8) lens epithelial explants under normal conditions
(lanes 1, 3, 5 and 7) and after heat shock (lanes 2, 4, 6 and 8) treatment are shown.  !-
actin (42 kDa) protein expression serves as an internal control and shows that equal
amounts of total protein were loaded in all lanes.
The bar graph represents the Hsp90 protein expression (percent of normal control, % ±
SEM) for control, FGF-2, TGF-!2 and TGF-!2/FGF-2 treated lens epithelial explant
extracts from normal culture and heat shocked conditions.  Statistical analysis (ANOVA:
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p % 0.05) shows that there is a significant treatment effect.  +The heat shocked control
(55.6±1.1%) and heat shocked TGF-!2 (73.6±6.0%) treated explants demonstrate
significant lower levels of Hsp90 expression when compared to normal control (100%)
epithelial explants.  Although there is also a decrease of Hsp90 expression in the normal




FGF-2 (normal (172.6±2.5%), heat
shocked (129.0±.3.3%)) and TGF-!2/FGF-2 (normal (187.0±5.3%), heat shocked
(157.0±5.3%)) explants show a significant increase of Hsp90 protein expression, with the
greatest increase in the TGF-!2/FGF-2 explants.  *In addition, the Hsp90 expression of
heat shocked FGF-2, TGF-!2 and TGF-!2/FGF-2 explants are significantly lower than




3.4.1 TGF-!2-induced EMT in rat lens epithelial explants
TGF-! is a multifunctional cytokine that plays crucial roles during development,
homeostasis and in certain pathological conditions, including ocular fibrotic diseases
such as glaucoma, ASC and PCO formation.
6, 23, 59-61
 Typically, TGF-! has inhibitory
effects on cells of epithelial origin, while it is mitogenic for smooth muscle cells and
fibroblasts.
60, 62
  Although all three TGF-! isoforms induced cataractous effects in rat lens
culture and epithelial explants, TGF-!2 is the predominant isoform expressed under
normal and abnormal ocular conditions.
13, 14, 22, 63
  Rat lenses in culture showed an age
dependent response to TGF-!.  Older rat lenses are more susceptible then younger rat
lenses to TGF-! induced cataract formation.52  Similarly, epithelial explants from 10 day
old rats demonstrate minimal response to TGF-! stimulation while explants from
weanling (21 day old) and adult rats show significant TGF-!-induced phenotype.  TGF-!
requires the presence of FGF to elicit a response in epithelial explants from 10 day old
rats.
13
  The age-dependent response to TGF-! is correlated with TGF-! receptor (TGF-
!RI and TGF-!RII) expressions in LECs at different ages.  Immunolocalization studies
of type I and II TGF-! receptors demonstrate greater reactivity in the weanling rat lens
than in the neonatal lens (3 day old).  The same study also shows that FGF-2 up-regulated
TGF-! receptor expression in 9 day old rat lens epithelial explants leads to an increase
susceptibility to TGF-!-induced response.64  The combined effects of TGF-!2 and FGF-2




  Hence, the interaction of FGF with TGF-! has been implicated in PCO
development.
17, 23
   The in-vitro rat lens epithelial explant model has proven to be useful
for uncovering the potential mechanisms involved in TGF-!-induced EMT in LECs.
Histological analysis of lens epithelial explants from 7-10 day old rats showed similar
morphology as described in previous experiments (Fig. 2).
13, 17, 23, 64
  Both control and
FGF-2 treated explants demonstrated a confluent monolayer of LECs that maintained
normal epithelial phenotype.  Treatment with TGF-!2/FGF-2 produced the greatest
mutilayering effect, while treatment with only TGF-!2 induces minimal response and
smaller distinct plaques.  Furthermore, the multilayer plaques developed in the heat
shocked TGF-!2/FGF-2 lens epithelial explants are less diffuse and expansive than those
found in the non-heat shocked TGF-!2/FGF-2 explants. The results from the current
study show that heat shock treatment of rat lens epithelial explants caused a reduction of
TGF-!-induced effects in the LECs.
3.4.2 Heat shock proteins in LECs
Heat shock proteins (Hsps) are ubiquitous proteins that are involved in
maintaining native protein conformations. Hsps are involved in various processes such as
refolding of damaged proteins, assisting in the folding of newly synthesized protein,
intracellular transportation of proteins through the endoplasmic reticulum, prevention of
protein aggregation and misfolding as well as the degradation of unfolded or partially
degraded proteins during homeostasis and stress conditions.
30, 48, 65
  It is suggested that a
decline of chaperone activities with age is associated with a loss of protein organization
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and the appearance of age-related cataracts.
30
  Hsp70, Hsp90 and "-crystallin exhibit
chaperoning activities in the lens.
29
  "-Crystallin binds to denatured proteins in the lens
and prevents unspecific protein aggregation that leads to cataract formation.
39, 42, 65
Subsequently, Hsp70 can renature the "-crystallin bound target proteins in an ATP-
dependent manner.
42
  In addition, Hsp70 deficient mice has demonstrated delayed wound
healing, increased corneal and lens opacity when compared to wild-type mice after
photoablation.
50
  Hsp90 is also present in the ocular system in the absence of stress.
However, it’s specific role in the LECs is less clear.
49
  Hsps are also involved in
regulating apoptosis.  Both "-crystallin and Hsp70 are reported to protect cells from
apoptosis.
66
  On the other hand, Hsp90 can either promote or prevent apoptosis,
depending on the apoptotic stimuli, tissue type, stages of development and the client
proteins being chaperoned.  For example, the inhibition of Hsp90 blocked lens apoptosis
in the blind cavefish.
44
   Hsp90 together with a client protein Akt (protein kinase B) can
protect human vascular endothelial cells from stress-induced apoptosis by inhibiting
apoptosis signal-regulating kinase 1 (ASK1) activity.
67
  Although there is significant
evidence showing the presence and localization of Hsps in the lens, their mechanisms and
specific functions are still not well defined.
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3.4.3 Effect of heat shock treatment on TGF-!2-induced apoptosis
Similar to previous findings, treatment with TGF-! induced a significant increase
in apoptotic cell death in the rat lens epithelial explants (Fig. 8).
57, 58
  The TGF-!2/FGF-2
treated explants show the greatest amount of apoptotic cell death.  In contrast, the FGF-2
treated explants demonstrated the least amount of TUNEL positive nuclei in comparison
to the control explants.  All cultured rat lens epithelial explants that were preconditioned
to heat stress show significant reduction of apoptotic cell death with respect to the non-
heat shock explants.  Therefore, heat shock treatment appeared to enhance the survival of
rat LECs during both normal culture conditions and following TGF-! treatment.
3.4.4 Effect of TGF-! on "-SMA expression, stress fibre and E-cadherin organization
"-SMA expression served as the main EMT marker in this study (Figs. 4 and 5).
The control cultured epithelial explants demonstrated a few positive "-SMA stained
LECs.  Similarly, non-cataractous human lenses have shown low-level expression of "-
SMA mRNA and protein expression in the LECs.
68
  The presence of "-SMA expression
in control LECs may also be due to elevated stress levels under culture conditions.
However, FGF-2 treated explants demonstrated negligible amount of "-SMA
immunoreactivity.  These results are in accordance with another study using 21 day old
rat lens epithelial explants which show no "-SMA expression in the FGF treated explants
and minimal "-SMA expression in the control explants.19  In addition, " - S M A
expression is a common feature found in primary bovine, rabbit and human cultured
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LECs in serum free medium.
69
  Treatment with TGF-!2 substantially increased the "-
SMA immunoreactivity and filamentous actin morphology, with the greatest effect
induced in the TGF-!2/FGF2 explants.  Previously, it was shown that TGF-! and FGF
have opposing effects on "-SMA expression.  While TGF-!2 increased "-SMA
expression, FGF-2 on the other hand decreased "-SMA expression in cultured bovine
LECs 
63
.  Furthermore the results demonstrated significant reduction of "-SMA
immunoreactivity and protein expression in the heat shocked control, TGF-!2 and TGF-
!2/FGF-2 explants when compared to their respective non-heat shocked treatment
groups.  Thus, heat shock treatment successfully reduced the TGF-! induction of
abnormal "-SMA expression in rat LECs.
E-cadherin is a transmembrane protein that is responsible for tight cell-to-cell
adhesion and the suppression of epithelial cell dissociation, as well as maintaining cell
polarity.  E-cadherin initiates calcium dependent binding of E-cadherin extracellular
domains on adjacent cells.  It is stabilized by the interaction of intracellular E-cadherin
domain with ", !  and ) catenins and subsequently forms a link with F-actin to form
functional adherens junctions.
54, 70
  The loss of E-cadherin and F-actin stress fibre
rearrangement are phenotypic changes associated with TGF-! mediated EMT.54, 56, 71-73
As with previous studies, TGF-! treatment induced the loss of E-cadherin expression and
delocalization E-cadherin from the cell junctions of the cultured rat LECs, with the
greatest loss found in the TGF-!2/FGF-2 treated explants (Figs. 6 and 7).56, 71, 72
However, the heat shocked TGF-!  (TGF-!  and TGF-!2/FGF-2) rat explants
demonstrated significantly greater levels of E-cadherin expression and less severe E-
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cadherin delocalization than the non-heat shocked TGF-! groups, while the control and
FGF-2 explanted rat LECs show normal immunolocalization of E-cadherin.
Interestingly, FGF-2 treated lens epithelial explants show significantly higher levels of E-
cadherin protein expression relative to the control explants (Fig. 7).  Our results are
consistent with another study that demonstrated an up-regulation of E-cadherin
expression in human pancreatic adenocarcinoma cell lines treated with FGF.
74
  In
addition to E-cadherin delocalization, substantial F-actin stress fibre formation and
reorganization is also seen in TGF-!2/FGF-2 treated lens epithelial explants (Fig. 3).
Although, heat shock treatment did not prevent TGF-! -induced stress fibre
reorganization, it did however, diminish the loss of E-cadherin expression and
organization in the TGF-! treated rat LECs.
3.4.5 "-Crystallin expression in LECs duringTGF-!-induced EMT
 "A-crystallin is primarily lens specific, while "B-crystallin is also found in the
heart, skeletal muscle, kidney, lung, and brain.
75-77
  It has been shown that the expression
of "B-crystallin is dramatically elevated under pathological conditions (heat disease,
multiple sclerosis and Alzheimer’s disease), thermal and chemical stress.
42, 76, 78, 79
  In
single "-crystallin knockout mice ("A- or "B-crystallin null), the remaining "-crystallin
may fully or partially compensate for the functions of the missing protein in the lens.
80
Targeted disruption of the mouse "A-crystallin gene caused an early-onset of cataract
development and significantly smaller lenses in comparison to the wild-type lenses. The
"A-crystallin knockout mouse lenses also undergo slower proliferation and higher
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apoptosis associated with mitosis,
38
 while the disruption of the mouse "B-crystallin gene
did not result in altered lens morphology or transparency.  Thus, it is suggested that "A-
crystallin plays a greater role in maintaining lens transparency than "B-crystallin.38, 80, 81
Results from the current study show an abundance of "B-crystallin protein expression
found in all the lens epithelial explants.  No differential "B-crystallin expression was
found between the treatment groups.  Western blot analysis of cultured human, mouse,
rat, rabbit, and bovine LECs also demonstrated an abundance of "B-crystallin, indicating
increased stress in the cultured environment.
82
  In contrast, results from this current study
showed differential "A-crystallin protein expressions between treatment groups.
Consistent with previous results, treatment of lens epithelial explants with FGF-2
significantly up-regulated the expression of "A-crystallin protein when compared to the
control explants.
82
  TGF-!2 reduces "A-crystallin protein expression, although the
decrease was not significant in the non-heat shocked TGF-! explants.  Another study has
also shown that FGF stimulated "A-crystallin promoter activity in rat lens epithelial
explants, while TGF-! inhibited the "A-crystallin promoter stimulation.83  "-Crystallin
can bind to actin filaments in the LECs and influence the cytoskeletal organization in the
lens.
80
  Thus, TGF-! induced reduction of "A-crystallin in the LECs may be associated
with cytoskeletal disorganization and a loss of epithelial phenotype.  Although "-
crystallin has been reported to protect cells from apoptosis, there is evidence that suggest
a decrease in "A-crystallin expression protect cells under stress conditions as part of the
antiapoptotic mechanism of proteasome inhibition in Murine LECs.
66
  In addition, the
down-regulation of "A-crystallin expression observed in hydrogen peroxide-resistant




  Hence, a decrease of "A-crystallin expression in the heat shocked control
and TGF-! (TGF-!2 and TGF-!2/FGF-2) explants with respect to the non-heat shocked
groups may also serve as protection against cultured and TGF-!-induced stresses.
3.4.6 The role of Hsp70 and Hsp90  in rat LECs during TGF-!-induced EMT
A basal level of inducible Hsp70 is expressed in the normal control rat epithelial
explants.
30, 45
  Treatment of lens explants with FGF-2 demonstrated reduced Hsp70
protein expression when compare to the control explants.  By contrast, TGF-! induced
significant increases in Hsp70 protein expression, with the greatest accumulation of
Hsp70 found in the TGF-!2/FGF-2 explants. The increase in expression of Hsp70 in the
TGF-! explants may be related to the increase in chaperoning functions needed to
prevent aggregation and denaturation of proteins, as well as to increase cell survival
during EMT. This is supported by a previous study, which demonstrated that an increase
of Hsp70 expression is associated with lens cell differentiation in embryonic chicken lens
cells.  Furthermore, Hsp70 induction is also observed in apoptotic cells.
46
  Hsp70 can also
inhibit apoptosis by inhibiting caspase-3 and stress activated protein kinase/c-Jun N-
terminal kinase (SAPK/JNK) activation.
85-87
  Hence, The up-regulation of Hsp70
expression maybe due to an increased need for anitapoptotic functions of Hsp70 in the
TGF-! treated explants.  In addition, the Hsp70 accumulation may also induced by the
apoptotic cells.
35
  Hsp70 protein expression was diminished in the heat shocked TGF-!
and FGF-2 explants when compared to the non-heat shocked explants.  This corresponds
with the reduction of apoptotic cell death found in the heat shocked TGF-!2 and TGF-
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!2/FGF-2 treated explants.  Thus, less Hsp70 chaperoning activity is needed in the heat
shocked TGF-! lens explants in respect to the non-heat shocked TGF-! lens explants.
It has been reported that heat shock induced Hsp70 mRNA accumulation in rat
LECs progressively declines after three hours of recovery.
47
  The results of our study
demonstrated that heat shock treatment enhanced the tolerance of LECs to TGF-!-
induced effects even at day four of explant culture after initial exposure.
Hsp90 is another major chaperone present in the normal cultured rat LECs.  FGF-
2 stimulated an up-regulation of Hsp90 expression in the rat lens epithelial explants, with
the greatest accumulation of Hsp90 found in the TGF-!2/FGF-2 treated explants.
Treatment with TGF-! alone show similar levels of Hsp90 expression as the control
explants.  The up-regulation of Hsp90 is related to increased cell proliferation and
survival in the FGF-2 treated rat epithelial explants.  Hsp90 is required for the
translocation of FGF-2 from the endosomes into the cytosol and cell nucleus where
nuclear FGF-2 can increase cell proliferation and survival of carcinoma cells.
88
  It has
been reported that inhibition of Hsp90 prevented FGF-2 induced mitogenic activity in
human breast cancer epithelial cells.  Thus, it is suggested that Hsp90 chaperone activity
is necessary for FGF-2 stimulated cell proliferation.
89
The proteasome is a multicatalytic cytoplasmic and nuclear complex that is
responsible for intracellular protein degradation and modulations of cell signaling
140
proteins, including those associated with TGF-!.90 TGF-! induced apoptosis and "-SMA
mRNA expression was blocked by proteasomal inhibition in human LECs.  The
proteasome inhibitor induced the accumulation of SnoN (Smad inhibitor protein) and
repressed the TGF-! signal progression in LECs.90  Another study shows that Hps90 and
"-crystallin plays a protective role in human lens proteasome activities against oxidative
insults.
91, 92
  Therefore increased Hsp90 expression in the TGF-!2/FGF-2 treated explants
may serve to protect proteasomal activities and enhanced TGF-! induced response.
Hsp90 expression is lowered in the heat shock treated explants of all treatment groups in
comparison to the respective non-heat shocked groups.  This also serves as an indication
that non-heat shocked LECs are under higher stress environment than the heat shocked
LECs.
In addition, both Hsp90 and Hsp70 can interact with cytoskeletal elements
including microtubules, microfilaments, actin and tublin.
49, 51, 93
  Thus, it is suggested that
Hsp90 and Hsp70 proteins are required during extensive cytoskeletal rearrangement and
disassembly in the TGF-!2/FGF-2 treated rat lens epithelial explants.51 Therefore TGF-
!-induced "-SMA and F-actin disorganization as well as E-cadherin disassembly are
concurrent with the up-regulation of Hsp70 and Hsp90 protein expressions along with
reduced expression of "A-crystallin expression.
In conclusion, the findings of this current study show that preconditioning of
cultured primary rat LECs to heat stress reduced the TGF-! induced EMT effect on the
LECs.  The most pronounced TGF-! induced EMT and plaque formation were found in
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the TGF-!2/FGF-2 treated rat lens epithelial explants, while treatment with FGF-2 alone
diminished the stress and enhanced the survival of LECs under normal culture conditions.
The heat shocked TGF-!2/FGF-2 lens epithelial explants demonstrated lower "-SMA
expression, E-cadherin disassociation and apoptosis than the non-heat shocked TGF-
!2/FGF-2 explants.   An increase in accumulation of Hsp70 and Hsp90 in these explants
suggests that there is a greater need for molecular chaperone activities in the TGF-
!2/FGF-2 treated LECs.  TGF-! also reduced "A-crystallin expression while "B-
crystallin expression produced no significant change relative to the control explants.  The
heat shocked LECs show lower "A-crystallin, Hsp70 and Hsp90 expressions when
compared to their respective non-heat shocked groups.  This study shows that molecular
chaperones may play a protective role in rat LECs during both normal culture and TGF-
!-induced stress.  Further investigation is required to determine the exact roles that heat
shock proteins play during TGF-!-induced EMT in the LECs.  Understanding the
mechanisms involved in lens epithelial cell transdifferentiation may provide potential
therapeutic candidates to prevent ASC and PCO development.
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General Conclusion
All three rodent models used in these experiments proved to be useful for
examining TGF-!-induced subcapsular cataract development.  The in-vitro rat whole
lenses and the lens epithelial explants demonstrated similar TGF-!-induced effects as
seen in the in-vivo TGF-!1 transgenic mice.  Treatment with TGF-!2 and overexpression
of TGF-!1 in rat and mouse lenses lead to multilayer plaque formation.  These lenses
subsequently exhibited an increase "-SMA expression and apoptosis in the LECs.  This
study also measured the optical quality of rat, transgenic TGF-!1 and Smad3 knockout
mouse lenses during ASC formation.  The results show that ASCs significantly reduced
lens optical quality and focus (refer to data in Chapter 1 and 2).  The in-vitro rat lens
epithelial explants provided a primary lens epithelial cell culture to specifically detect
TGF-! cellular effects during EMT (Chapter 3).
The development of these subcapsular cataracts involves EMT.  EMT progression
is characterized by the transdifferentiation of lens epithelial cells into myofibroblastic
cells which cause the accumulation of ECM. 
18-20
  Under physiological conditions, TGF-!
in the lens and ocular media mainly exists in its latent form, whereas biologically active
TGF-! has been detected in the ocular media from patients suffering with ASC.21, 22
Previously, in-vitro rat lens culture and lens epithelial explants have shown that all three
TGF-! isoforms (TGF-!1, TGF-!2 and TGF-!3) can induce cataractous changes.
However, TGF-!1 is 10 times less potent than TGF-!2 and TGF-!3.14
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TGF-! modified ECM by inducing the expression of MMPs and other enzymes
involved in matrix remodeling.
23
  A MMP inhibitor (Ilomastat) is also used in chapter 1
to investigate the role of MMPs in TGF-!-induced subcapsular cataract development.
Through the breakdown and remodeling of extracellular matrix, MMPs play an essential
role in normal physiological processes such as embryonic development, morphogenesis,
reproduction, and tissue resorption and remodeling.
24
  MMPs are secreted as inactive
zymogens (pro-MMPs) and require proteolytic removal of an amino-terminal pro-
sequence for them to function.
25
  Various growth factors, hormones, cytokines, cell-to-
matrix, cell-to-cell interactions and cellular transformation transcriptionally regulate
MMP expression.
24, 26
  It has been suggested that over-expression of MMPs can promote
tumor invasion and angiogenesis.
27
  Interestingly, MMP2 (gelatinase A, 72 kD) and
MMP9 (gelatinase B, 92 kD) are the most widely studied members of the MMP family in
the eye.
23, 28
  Both MMP2 and MMP9 are up-regulated during abnormal ocular conditions
such as posterior capsule opacification, proliferative diabetic retinopathy and epithelial
wound healing.
29-32
  The expression of MMP2 and MMP9 is both positively and
negatively regulated by TGF-!.23  The results from this experiment show that prolonged
exposure (6 days) of cultured rat lenses to TGF-!2 plus 25 µM Ilomastat effectively
inhibited the formation of subcapsular plaques and lens opacities. Optical analysis
demonstrated that there are no significant differences in BVD errors between the TGF-!2
+ 25 µM Ilomastat treated lenses and control lenses.  Also the treatment with Ilomastat
significantly reduced the effects of TGF-!2 on cultured rat lenses, as shown in the optical
results.  Ilomastat is a general MMP inhibitor that has been shown to prevent lens capsule
contraction, and human lens and corneal epithelial cell migration.
33, 34
  However, the
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mechanisms that are involved in subcapsular cataract formation in respect to the
relationship between MMPs and TGF-! are still not fully understood.
Chapter 2 shows that transgenic, in vivo expression of TGF-!1 in the lens
promotes the formation of ASCs in the absence of Smad3.  The fact that the subcapsular
plaques in the TGF-!1/Smad3 null mice are reduced in size, with less "-SMA expression
and substantially less collagen deposition, suggests that while Smad3 signaling is
sufficient for the formation of ASC plaques, it is not necessary.  In addition, all of the
TGF-!1 (TGF-!1/Smad3+/+, TGF-!1/Smad3-/- and TGF-!1/Smad3+/-) transgenic lenses
which exhibited ASC plaques show significantly larger BVD errors (decreased sharpness
of focus) relative to the BVD errors of the wild-type lenses, which are devoid of plaques.
Importantly, the BVD errors of TGF-!1/Smad3-/- lenses are significantly lower then both
TGF-!1/Smad3+/+ and TGF-!1/Smad3+/- lenses, demonstrating the ability of the scanning
laser instrument to discern the effects of size of the subcapsular plaques on optical
quality.
TGF-! signaling is mediated by a heterodimeric complex of two types of
transmembrane serine/threonine kinase receptors.  TGF-! binds to the receptor complex
causing the type II receptor kinase to phosphorylate and thereby activate the type I
receptor kinase. The type I receptor kinase then phosphorylates the receptor activated
Smads (R-Smads), Smad2 and 3.
35, 36
  Once activated, the R-Smads bind to Smad 4 and
translocate into the nucleus and along with other transcription factors, bind to gene
promoters to activate or repress transcription.  Thus, it could be surmised that Smad2
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activation may have compensated for the loss of Smad3 in the lens and contributed to the
TGF-!-induced EMT in the TGF-!1/Smad3-/- lens epithelium.  However, while both
Smad2 and Smad3 can mediate TGF-! and activin signaling, they clearly have non-
redundant functions.  For example, homozygous mice with targeted disruptions in the
Smad2 gene exhibit embryonic lethality during gastrulation 
37, 38
, whereas, homozygous
Smad3 null mice are viable and survive to adulthood.
39, 40
  Smad3 and Smad2 have also
been shown to have different gene-regulatory functions and Smad3, not Smad2, has been
linked to fibrotic events.
39, 41, 42
  Future studies using the in-vivo transgenic mouse model
will be aimed at determining the requirement for Smad-dependent and Smad-independent
signaling pathways in various aspects of the ASC phenotype.  Uncovering the specific
TGF-! signaling mechanisms may provide potential therapeutic targets for ASC and
closely related ocular fibrotic diseases, such as secondary cataract or PCO.
Finally the role of molecular chaperones in TGF-!2-induced EMT in rat lens
epithelial explants was investigated in chapter 3.  FGF-2 was also use to exacerbate the
effects of TGF-! as mentioned previously.  Heat shock proteins (Hsps) are ubiquitous
proteins that are involved in maintaining native protein conformations. Hsps are involved
in various processes such as refolding of damaged proteins, assisting in the folding of
newly synthesized protein, intracellular transportation of proteins through the
endoplasmic reticulum, prevention of protein aggregation and misfolding as well as the
degradation of unfolded or partially degraded proteins during homeostasis and stress
conditions.
2, 43, 44
  It is suggested that a decline of chaperone activities with age is




  Hsp70, Hsp90 and "-crystallin exhibit chaperoning activities in lens.45  " -
Crystallin binds to denatured proteins in the lens and prevents unspecific protein
aggregation that leads to cataract formation.
43, 46, 47
  Subsequently, Hsp70 can renature the
"-crystallin bound target proteins in an ATP-dependent manner.46  In addition, Hsp70
deficient mice has demonstrated delayed wound healing, increased corneal and lens
opacity when compared to wild-type mice after photoablation.
48
  Hsp90 is also present in
the ocular system in the absence of stress.  However it’s specific role in the LECs is less
clear.
49
  Hsps are also involved in regulating apoptosis.  Both "-crystallin and Hsp70 are
reported to protect cells from apoptosis.
50
  On the other hand, Hsp90 can either promote
or prevent apoptosis depending on the apoptotic stimuli, tissue type, stages of
development and the client proteins being chaperoned.
51
The preconditioning of cultured primary rat LECs to heat stress reduced the TGF-
!-induced EMT effect on the LECs.  The most pronounced TGF-!-induced EMT and
plaque formation were found in the TGF-!2/FGF-2 treated rat lens epithelial explants.
Treatment with only FGF-2 diminished the stress and enhanced the survival of LECs
under normal culture conditions. The heat shocked TGF-!2/FGF-2 lens epithelial
explants demonstrated lower "-SMA expression, E-cadherin disassociation and apoptosis
than the non-heat shocked TGF-!2/FGF-2 explants.   An increased accumulation of
Hsp70 and Hsp90 in these explants suggests that there is a greater need for molecular
chaperone activities in the TGF-!2/FGF-2 treated LECs.  TGF-! also reduced "A-
crystallin expression while "B-crystallin expression showed no significant change
relative to the control explants.  The heat-shocked LECs shows lower "A-crystallin,
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Hsp70 and Hsp90 expressions when compare to their respective non-heat shocked
groups.  This study shows that molecular chaperones may play a protective role in rat
LECs during both culture and TGF-!-induced stress.  Further investigation is required to
determine the exact roles that heat shock proteins play during TGF-!-induced EMT in the
LECs.
In conclusion, TGF-! induced the formation of subcapsular cataracts and reduced
the optical function of the lens.  Inhibition of MMPs prevented ASCs, while Smad3 gene
knockout and heat shock treatment only diminished the effects of TGF-!.  These results
indicate that various proteins and signaling pathways are associated with subcapsular
cataract development.  MMPs, Smad proteins, and heat shock proteins may serve as
therapeutic candidates for ASCs and PCO.  However, more studies are required to
determine the exact mechanisms involved.
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